SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell Source, Inc. – ‘10-K’ for 12/31/21 – ‘JSON’

On:  Friday, 4/15/22, at 5:12pm ET   ·   For:  12/31/21   ·   Accession #:  1493152-22-10133   ·   File #:  0-55413

Previous ‘10-K’:  ‘10-K’ on 4/15/21 for 12/31/20   ·   Next & Latest:  ‘10-K’ on 8/8/23 for 12/31/22   ·   28 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/22  Cell Source, Inc.                 10-K       12/31/21   75:11M                                    M2 Compliance LLC/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.93M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     22K 
 3: EX-10.36A   Material Contract                                   HTML     50K 
 4: EX-10.39B   Material Contract                                   HTML     50K 
 5: EX-10.63A   Material Contract                                   HTML     30K 
 6: EX-10.68    Material Contract                                   HTML     53K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
14: R1          Cover                                               HTML     87K 
15: R2          Consolidated Balance Sheets                         HTML    117K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
17: R4          Consolidated Statements of Operations               HTML     78K 
18: R5          Consolidated Statements of Changes in               HTML    167K 
                Stockholders' Deficiency                                         
19: R6          Consolidated Statements of Cash Flows               HTML    165K 
20: R7          Business Organization, Nature of Operations and     HTML     28K 
                Risks and Uncertainties                                          
21: R8          Going Concern and Management?s Plans                HTML     30K 
22: R9          Summary of Significant Accounting Policies          HTML     94K 
23: R10         Fair Value                                          HTML    134K 
24: R11         Accrued Expenses                                    HTML     40K 
25: R12         Accrued Compensation                                HTML     42K 
26: R13         Advances Payable                                    HTML     27K 
27: R14         Notes Payable                                       HTML    222K 
28: R15         Income Taxes                                        HTML     61K 
29: R16         Stockholders? Deficiency                            HTML    241K 
30: R17         Commitments and Contingencies                       HTML     46K 
31: R18         Related Party Transactions                          HTML     28K 
32: R19         Subsequent Events                                   HTML     38K 
33: R20         Summary of Significant Accounting Policies          HTML    128K 
                (Policies)                                                       
34: R21         Summary of Significant Accounting Policies          HTML     42K 
                (Tables)                                                         
35: R22         Fair Value (Tables)                                 HTML    131K 
36: R23         Accrued Expenses (Tables)                           HTML     38K 
37: R24         Accrued Compensation (Tables)                       HTML     41K 
38: R25         Notes Payable (Tables)                              HTML    110K 
39: R26         Income Taxes (Tables)                               HTML     57K 
40: R27         Stockholders? Deficiency (Tables)                   HTML    160K 
41: R28         Going Concern and Management?s Plans (Details       HTML     48K 
                Narrative)                                                       
42: R29         Schedule of Weighted Average Dilutive Common        HTML     35K 
                Shares Anti-dilutive (Details)                                   
43: R30         Schedule of Weighted Average Dilutive Common        HTML     22K 
                Shares Anti-dilutive (Details) (Parenthetical)                   
44: R31         Summary of Significant Accounting Policies          HTML     45K 
                (Details Narrative)                                              
45: R32         Schedule of Changes in Fair Value of Liabilities    HTML     68K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
46: R33         Schedule of Assumptions Used for Valuation of       HTML     40K 
                Level 3 Liabilities (Details)                                    
47: R34         Fair Value (Details Narrative)                      HTML     24K 
48: R35         Schedule of Accrued Expenses (Details)              HTML     36K 
49: R36         Schedule of Accrued Compensation (Details)          HTML     42K 
50: R37         Advances Payable (Details Narrative)                HTML     33K 
51: R38         Schedule of Notes Payable (Details)                 HTML     36K 
52: R39         Schedule of Notes Payable Due to Related Parties    HTML     28K 
                (Details)                                                        
53: R40         Schedule of Convertible Notes Payable (Details)     HTML     39K 
54: R41         Schedule of Convertible Notes Payable (Details)     HTML     34K 
                (Parenthetical)                                                  
55: R42         Schedule of Convertible Notes Payable Due to        HTML     27K 
                Related Parties (Details)                                        
56: R43         Schedule of Convertible Notes Payable Due to        HTML     24K 
                Related Parties (Details) (Parenthetical)                        
57: R44         Notes Payable (Details Narrative)                   HTML    328K 
58: R45         Schedule of Income Before Income Taxes (Details)    HTML     30K 
59: R46         Schedule of Component of Income Tax Expenses        HTML     38K 
                (Benefit) (Details)                                              
60: R47         Schedule of Effective Income Tax Rate               HTML     41K 
                Reconciliation (Details)                                         
61: R48         Schedule of Deferred Tax Assets (Details)           HTML     36K 
62: R49         Income Taxes (Details Narrative)                    HTML     35K 
63: R50         Schedule of Warrant Activity (Details)              HTML     56K 
64: R51         Schedule of Outstanding and Exercisable (Details)   HTML     50K 
65: R52         Schedule of Stock Options Assumption Used           HTML     37K 
                (Details)                                                        
66: R53         Summary of Stock Option Activity (Details)          HTML     54K 
67: R54         Stockholders? Deficiency (Details Narrative)        HTML    281K 
68: R55         Commitments and Contingencies (Details Narrative)   HTML     69K 
69: R56         Related Party Transactions (Details Narrative)      HTML     32K 
70: R57         Subsequent Events (Details Narrative)               HTML     84K 
73: XML         IDEA XML File -- Filing Summary                      XML    129K 
71: XML         XBRL Instance -- form10-k_htm                        XML   2.14M 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX    103K 
10: EX-101.CAL  XBRL Calculations -- clcs-20211231_cal               XML    182K 
11: EX-101.DEF  XBRL Definitions -- clcs-20211231_def                XML    689K 
12: EX-101.LAB  XBRL Labels -- clcs-20211231_lab                     XML   1.37M 
13: EX-101.PRE  XBRL Presentations -- clcs-20211231_pre              XML    966K 
 9: EX-101.SCH  XBRL Schema -- clcs-20211231                         XSD    210K 
74: JSON        XBRL Instance as JSON Data -- MetaLinks              397±   546K 
75: ZIP         XBRL Zipped Folder -- 0001493152-22-010133-xbrl      Zip    738K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"instance":  {
    "form10-k.htm":  {
        "axisCustom":  0,
        "axisStandard":  27,
        "contextCount":  291,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "clcs-20211231_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "clcs-20211231_def.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "form10-k.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "clcs-20211231_lab.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "clcs-20211231_pre.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "clcs-20211231.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
                    "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
                    "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
                    "https://xbrl.sec.gov/country/2021/country-2021.xsd",
                    "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
                    ]
                }
            },
        "elementCount":  630,
        "entityCount":  1,
        "hidden":  {
            "http://cellsource.com/20211231":  75,
            "http://fasb.org/us-gaap/2021-01-31":  104,
            "http://xbrl.sec.gov/dei/2021q4":  3,
            "total":  182
            },
        "keyCustom":  120,
        "keyStandard":  283,
        "memberCustom":  59,
        "memberStandard":  24,
        "nsprefix":  "CLCS",
        "nsuri":  "http://cellsource.com/20211231",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "00000001 - Document - Cover",
                "role":  "http://cellsource.com/role/Cover",
                "shortName":  "Cover",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000010 - Disclosure - Fair Value",
                "role":  "http://cellsource.com/role/FairValue",
                "shortName":  "Fair Value",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000011 - Disclosure - Accrued Expenses",
                "role":  "http://cellsource.com/role/AccruedExpenses",
                "shortName":  "Accrued Expenses",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "CLCS:AccruedCompensationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000012 - Disclosure - Accrued Compensation",
                "role":  "http://cellsource.com/role/AccruedCompensation",
                "shortName":  "Accrued Compensation",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "CLCS:AccruedCompensationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OtherLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000013 - Disclosure - Advances Payable",
                "role":  "http://cellsource.com/role/AdvancesPayable",
                "shortName":  "Advances Payable",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OtherLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000014 - Disclosure - Notes Payable",
                "role":  "http://cellsource.com/role/NotesPayable",
                "shortName":  "Notes Payable",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000015 - Disclosure - Income Taxes",
                "role":  "http://cellsource.com/role/IncomeTaxes",
                "shortName":  "Income Taxes",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000016 - Disclosure - Stockholders\u2019 Deficiency",
                "role":  "http://cellsource.com/role/StockholdersDeficiency",
                "shortName":  "Stockholders\u2019 Deficiency",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000017 - Disclosure - Commitments and Contingencies",
                "role":  "http://cellsource.com/role/CommitmentsAndContingencies",
                "shortName":  "Commitments and Contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000018 - Disclosure - Related Party Transactions",
                "role":  "http://cellsource.com/role/RelatedPartyTransactions",
                "shortName":  "Related Party Transactions",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000019 - Disclosure - Subsequent Events",
                "role":  "http://cellsource.com/role/SubsequentEvents",
                "shortName":  "Subsequent Events",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000002 - Statement - Consolidated Balance Sheets",
                "role":  "http://cellsource.com/role/BalanceSheets",
                "shortName":  "Consolidated Balance Sheets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConsolidationPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)",
                "role":  "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
                "shortName":  "Summary of Significant Accounting Policies (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConsolidationPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)",
                "role":  "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesTables",
                "shortName":  "Summary of Significant Accounting Policies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:FairValueDisclosuresTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000022 - Disclosure - Fair Value (Tables)",
                "role":  "http://cellsource.com/role/FairValueTables",
                "shortName":  "Fair Value (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:FairValueDisclosuresTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000023 - Disclosure - Accrued Expenses (Tables)",
                "role":  "http://cellsource.com/role/AccruedExpensesTables",
                "shortName":  "Accrued Expenses (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "CLCS:AccruedCompensationTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "CLCS:AccruedCompensationTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000024 - Disclosure - Accrued Compensation (Tables)",
                "role":  "http://cellsource.com/role/AccruedCompensationTables",
                "shortName":  "Accrued Compensation (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "CLCS:AccruedCompensationTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "CLCS:AccruedCompensationTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShortTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000025 - Disclosure - Notes Payable (Tables)",
                "role":  "http://cellsource.com/role/NotesPayableTables",
                "shortName":  "Notes Payable (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShortTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000026 - Disclosure - Income Taxes (Tables)",
                "role":  "http://cellsource.com/role/IncomeTaxesTables",
                "shortName":  "Income Taxes (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000027 - Disclosure - Stockholders\u2019 Deficiency (Tables)",
                "role":  "http://cellsource.com/role/StockholdersDeficiencyTables",
                "shortName":  "Stockholders\u2019 Deficiency (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000028 - Disclosure - Going Concern and Management\u2019s Plans (Details Narrative)",
                "role":  "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                "shortName":  "Going Concern and Management\u2019s Plans (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "CLCS:WorkingCapitalSurplusDeficiency",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000029 - Disclosure - Schedule of Weighted Average Dilutive Common Shares Anti-dilutive (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails",
                "shortName":  "Schedule of Weighted Average Dilutive Common Shares Anti-dilutive (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:PreferredStockParOrStatedValuePerShare",
                        "span",
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
                "role":  "http://cellsource.com/role/BalanceSheetsParenthetical",
                "shortName":  "Consolidated Balance Sheets (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:CommonStockSharesIssued",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "link:footnote",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentConvertibleConversionPrice1",
                    "reportCount":  1,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000030 - Disclosure - Schedule of Weighted Average Dilutive Common Shares Anti-dilutive (Details) (Parenthetical)",
                "role":  "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetailsParenthetical",
                "shortName":  "Schedule of Weighted Average Dilutive Common Shares Anti-dilutive (Details) (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  null
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
                "role":  "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                "shortName":  "Summary of Significant Accounting Policies (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                        "us-gaap:FairValueDisclosuresTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "CLCS:FairValueInputsMeasuredOnRecurringBasisBeginningBalance",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000032 - Disclosure - Schedule of Changes in Fair Value of Liabilities Measured at Fair Value on a Recurring Basis (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
                "shortName":  "Schedule of Changes in Fair Value of Liabilities Measured at Fair Value on a Recurring Basis (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                        "us-gaap:FairValueDisclosuresTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "CLCS:FairValueInputsMeasuredOnRecurringBasisBeginningBalance",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
                        "us-gaap:FairValueDisclosuresTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DerivativeLiabilityMeasurementInput",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000033 - Disclosure - Schedule of Assumptions Used for Valuation of Level 3 Liabilities (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails",
                "shortName":  "Schedule of Assumptions Used for Valuation of Level 3 Liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
                        "us-gaap:FairValueDisclosuresTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DerivativeLiabilityMeasurementInput",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:FairValueDisclosuresTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000034 - Disclosure - Fair Value (Details Narrative)",
                "role":  "http://cellsource.com/role/FairValueDetailsNarrative",
                "shortName":  "Fair Value (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "CLCS:AccruedResearchAndDevelopment",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000035 - Disclosure - Schedule of Accrued Expenses (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails",
                "shortName":  "Schedule of Accrued Expenses (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "CLCS:AccruedResearchAndDevelopment",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "CLCS:AccruedCompensationTableTextBlock",
                        "CLCS:AccruedCompensationTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AccruedIncomeTaxesCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000036 - Disclosure - Schedule of Accrued Compensation (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails",
                "shortName":  "Schedule of Accrued Compensation (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "CLCS:AccruedCompensationTableTextBlock",
                        "CLCS:AccruedCompensationTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AccruedIncomeTaxesCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:OtherLiabilitiesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2020-05-052020-05-06",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "CLCS:ProceedsFromAdvancesPayable",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000037 - Disclosure - Advances Payable (Details Narrative)",
                "role":  "http://cellsource.com/role/AdvancesPayableDetailsNarrative",
                "shortName":  "Advances Payable (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:OtherLiabilitiesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2020-05-052020-05-06",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "CLCS:ProceedsFromAdvancesPayable",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NotesPayableCurrent",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000038 - Disclosure - Schedule of Notes Payable (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfNotesPayableDetails",
                "shortName":  "Schedule of Notes Payable (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShortTermDebtTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_custom_NotesIssuedOnMarch26TwoThousandFifteenMember",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:NotesPayableCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000039 - Disclosure - Schedule of Notes Payable Due to Related Parties (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails",
                "shortName":  "Schedule of Notes Payable Due to Related Parties (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "CLCS:NotesPayableDueToRelatedPartiesTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_custom_NoteIssuedOnNovemberTwentySixTwoThousandFourteenMember",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000004 - Statement - Consolidated Statements of Operations",
                "role":  "http://cellsource.com/role/StatementsOfOperations",
                "shortName":  "Consolidated Statements of Operations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "CLCS:ResearchAndDevelopmentRelatedParty",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ConvertibleDebtTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ConvertibleNotesPayable",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000040 - Disclosure - Schedule of Convertible Notes Payable (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                "shortName":  "Schedule of Convertible Notes Payable (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ConvertibleDebtTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_custom_ConvertibleNotesIssuedOnJuly24TwoThousandFifteenMember",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:ConvertibleNotesPayable",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ConvertibleDebtTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_custom_ConvertibleNotesIssuedOnJuly24TwoThousandFifteenMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000041 - Disclosure - Schedule of Convertible Notes Payable (Details) (Parenthetical)",
                "role":  "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical",
                "shortName":  "Schedule of Convertible Notes Payable (Details) (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ConvertibleDebtTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_custom_ConvertibleNotesIssuedOnJuly24TwoThousandFifteenMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "CLCS:ConvertibleNotesPayableDueToRelatedPartiesTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ConvertibleDebtNoncurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000042 - Disclosure - Schedule of Convertible Notes Payable Due to Related Parties (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails",
                "shortName":  "Schedule of Convertible Notes Payable Due to Related Parties (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "CLCS:ConvertibleNotesPayableDueToRelatedPartiesTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ConvertibleDebtNoncurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "CLCS:ConvertibleNotesPayableDueToRelatedPartiesTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_custom_ConvertibleNotesIssuedOnOctoberTwentyEightTwoThousandNineteenMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscountCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000043 - Disclosure - Schedule of Convertible Notes Payable Due to Related Parties (Details) (Parenthetical)",
                "role":  "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetailsParenthetical",
                "shortName":  "Schedule of Convertible Notes Payable Due to Related Parties (Details) (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "CLCS:ConvertibleNotesPayableDueToRelatedPartiesTableTextBlock",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_custom_ConvertibleNotesIssuedOnOctoberTwentyEightTwoThousandNineteenMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentUnamortizedDiscountCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2019-01-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000044 - Disclosure - Notes Payable (Details Narrative)",
                "role":  "http://cellsource.com/role/NotesPayableDetailsNarrative",
                "shortName":  "Notes Payable (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:InterestExpenseDebt",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000045 - Disclosure - Schedule of Income Before Income Taxes (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails",
                "shortName":  "Schedule of Income Before Income Taxes (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000046 - Disclosure - Schedule of Component of Income Tax Expenses (Benefit) (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails",
                "shortName":  "Schedule of Component of Income Tax Expenses (Benefit) (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R47":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000047 - Disclosure - Schedule of Effective Income Tax Rate Reconciliation (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
                "shortName":  "Schedule of Effective Income Tax Rate Reconciliation (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R48":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000048 - Disclosure - Schedule of Deferred Tax Assets (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails",
                "shortName":  "Schedule of Deferred Tax Assets (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R49":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLossCarryforwards",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000049 - Disclosure - Income Taxes (Details Narrative)",
                "role":  "http://cellsource.com/role/IncomeTaxesDetailsNarrative",
                "shortName":  "Income Taxes (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLossCarryforwards",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficiency",
                "role":  "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                "shortName":  "Consolidated Statements of Changes in Stockholders' Deficiency",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2019-12-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R50":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000050 - Disclosure - Schedule of Warrant Activity (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfWarrantActivityDetails",
                "shortName":  "Schedule of Warrant Activity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R51":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_us-gaap_WarrantMember24401984",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000051 - Disclosure - Schedule of Outstanding and Exercisable (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails",
                "shortName":  "Schedule of Outstanding and Exercisable (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_us-gaap_WarrantMember24401984",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R52":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-012021-12-31_us-gaap_StockOptionMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000052 - Disclosure - Schedule of Stock Options Assumption Used (Details)",
                "role":  "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                "shortName":  "Schedule of Stock Options Assumption Used (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-012021-12-31_us-gaap_StockOptionMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R53":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000053 - Disclosure - Summary of Stock Option Activity (Details)",
                "role":  "http://cellsource.com/role/SummaryOfStockOptionActivityDetails",
                "shortName":  "Summary of Stock Option Activity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R54":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2020-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockSharesAuthorized",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000054 - Disclosure - Stockholders\u2019 Deficiency (Details Narrative)",
                "role":  "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                "shortName":  "Stockholders\u2019 Deficiency (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-07-26",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    }
                },
            "R55":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000055 - Disclosure - Commitments and Contingencies (Details Narrative)",
                "role":  "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                "shortName":  "Commitments and Contingencies (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2019-10-012019-10-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R56":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000056 - Disclosure - Related Party Transactions (Details Narrative)",
                "role":  "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative",
                "shortName":  "Related Party Transactions (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2021-12-31_srt_DirectorMember",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "CLCS:LoanPenaltiesAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R57":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2019-01-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000057 - Disclosure - Subsequent Events (Details Narrative)",
                "role":  "http://cellsource.com/role/SubsequentEventsDetailsNarrative",
                "shortName":  "Subsequent Events (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:SubsequentEventsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "AsOf2022-03-31_us-gaap_SubsequentEventMember",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:SharesIssuedPricePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000006 - Statement - Consolidated Statements of Cash Flows",
                "role":  "http://cellsource.com/role/StatementsOfCashFlows",
                "shortName":  "Consolidated Statements of Cash Flows",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:AmortizationOfFinancingCostsAndDiscounts",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000007 - Disclosure - Business Organization, Nature of Operations and Risks and Uncertainties",
                "role":  "http://cellsource.com/role/BusinessOrganizationNatureOfOperationsAndRisksAndUncertainties",
                "shortName":  "Business Organization, Nature of Operations and Risks and Uncertainties",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000008 - Disclosure - Going Concern and Management\u2019s Plans",
                "role":  "http://cellsource.com/role/GoingConcernAndManagementsPlans",
                "shortName":  "Going Concern and Management\u2019s Plans",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000009 - Disclosure - Summary of Significant Accounting Policies",
                "role":  "http://cellsource.com/role/SummaryOfSignificantAccountingPolicies",
                "shortName":  "Summary of Significant Accounting Policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "form10-k.htm",
                    "contextRef":  "From2021-01-01to2021-12-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  90,
        "tag":  {
            "CLCS_AccrualOfEarnedPreferredStockDividends":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrual of earned preferred stock dividends.",
                            "label":  "Accrual of earned preferred stock dividends"
                            }
                        }
                    },
                "localname":  "AccrualOfEarnedPreferredStockDividends",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccrualOfWarrantsPayableInConnectionWithIssuanceOfConvertibleNotesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrual of warrants payable in connection with issuance of convertible notes payable.",
                            "label":  "Accrual of warrants payable in connection with issuance of convertible notes payable"
                            }
                        }
                    },
                "localname":  "AccrualOfWarrantsPayableInConnectionWithIssuanceOfConvertibleNotesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedCompensation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued compensation.",
                            "label":  "[custom:AccruedCompensation-0]"
                            }
                        }
                    },
                "localname":  "AccruedCompensation",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedCompensationCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued compensation common stock.",
                            "label":  "Accrued compensation-common stock"
                            }
                        }
                    },
                "localname":  "AccruedCompensationCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedCompensationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Compensation [Member]",
                            "label":  "Accrued Compensation [Member]"
                            }
                        }
                    },
                "localname":  "AccruedCompensationMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_AccruedCompensationTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued compensation [Table text block].",
                            "label":  "Schedule of Accrued Compensation"
                            }
                        }
                    },
                "localname":  "AccruedCompensationTableTextBlock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/AccruedCompensationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "CLCS_AccruedCompensationTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued compensation [Text Block]",
                            "label":  "AccruedCompensationTextBlock",
                            "verboseLabel":  "Accrued Compensation"
                            }
                        }
                    },
                "localname":  "AccruedCompensationTextBlock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/AccruedCompensation"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "CLCS_AccruedDividendDesignation":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued dividend designation.",
                            "label":  "Accrued dividend designation, value"
                            }
                        }
                    },
                "localname":  "AccruedDividendDesignation",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedDividendPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued dividend payable.",
                            "label":  "AccruedDividendPayable",
                            "verboseLabel":  "Accrued dividend payable"
                            }
                        }
                    },
                "localname":  "AccruedDividendPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedExpensesRelatedPartiesCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued expenses related parties current.",
                            "label":  "Accrued expenses - related parties"
                            }
                        }
                    },
                "localname":  "AccruedExpensesRelatedPartiesCurrent",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestAndPenalties":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued interest and penalties.",
                            "label":  "Accrued interest and penalities"
                            }
                        }
                    },
                "localname":  "AccruedInterestAndPenalties",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued interest common stock.",
                            "label":  "Accrued interest- common stock"
                            }
                        }
                    },
                "localname":  "AccruedInterestCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestConvertedIntoNotesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued interest converted into notes payable.",
                            "label":  "Accrued interest converted into notes payable"
                            }
                        }
                    },
                "localname":  "AccruedInterestConvertedIntoNotesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Interest [Member]",
                            "label":  "Accrued Interest [Member]"
                            }
                        }
                    },
                "localname":  "AccruedInterestMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_AccruedInterestRelatedPartiesCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued intererst related parties current.",
                            "label":  "Accrued interest - related parties"
                            }
                        }
                    },
                "localname":  "AccruedInterestRelatedPartiesCurrent",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestWarrantOne":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued interest warrant one.",
                            "label":  "Accrual of warrant obligation"
                            }
                        }
                    },
                "localname":  "AccruedInterestWarrantOne",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestWarrantRelatedParty":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued interest warrant related party.",
                            "label":  "Accrued interest- warrants- related party"
                            }
                        }
                    },
                "localname":  "AccruedInterestWarrantRelatedParty",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestWarrantsOne":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued Interest Warrant One.",
                            "label":  "Accrued interest - warrants"
                            }
                        }
                    },
                "localname":  "AccruedInterestWarrantsOne",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestWarrantsThree":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued interest warrants three.",
                            "label":  "AccruedInterestWarrantsThree",
                            "verboseLabel":  "Accrued interest - warrants"
                            }
                        }
                    },
                "localname":  "AccruedInterestWarrantsThree",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedInterestWarrantsTwo":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued interest warrants two.",
                            "label":  "Accrued interest- warrants"
                            }
                        }
                    },
                "localname":  "AccruedInterestWarrantsTwo",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedLegalFees":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued legal fees.",
                            "label":  "Accrued legal fees"
                            }
                        }
                    },
                "localname":  "AccruedLegalFees",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedResearchAndDevelopment":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued research and development.",
                            "label":  "Accrued research and development"
                            }
                        }
                    },
                "localname":  "AccruedResearchAndDevelopment",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedSeveranceCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued severance current.",
                            "label":  "Severance"
                            }
                        }
                    },
                "localname":  "AccruedSeveranceCurrent",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedSocialSecurityCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued social security current.",
                            "label":  "Social security"
                            }
                        }
                    },
                "localname":  "AccruedSocialSecurityCurrent",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AccruedThirdPartyPayments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accrued third party payments.",
                            "label":  "Accrued third-party payments"
                            }
                        }
                    },
                "localname":  "AccruedThirdPartyPayments",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AdditionalAccruedDividendParValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additional Accrued Dividend Par Value.",
                            "label":  "Additional accrued dividend par value"
                            }
                        }
                    },
                "localname":  "AdditionalAccruedDividendParValue",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "CLCS_AdvancesPayableCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Advances payable current.",
                            "label":  "Advances payable"
                            }
                        }
                    },
                "localname":  "AdvancesPayableCurrent",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AdvancesPayableRelatedPartyCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Advances payable related party current.",
                            "label":  "Advances payable - related party"
                            }
                        }
                    },
                "localname":  "AdvancesPayableRelatedPartyCurrent",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AmortizationOfDebtDiscountRelatedParty":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amortization of debt discount - related party.",
                            "label":  "AmortizationOfDebtDiscountRelatedParty",
                            "negatedLabel":  "Amortization of debt discount - related party"
                            }
                        }
                    },
                "localname":  "AmortizationOfDebtDiscountRelatedParty",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AmountPayableForResearchServices":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount payable for research services.",
                            "label":  "[custom:AmountPayableForResearchServices-0]"
                            }
                        }
                    },
                "localname":  "AmountPayableForResearchServices",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AmountPayableUnderAgreement":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount payable under agreement.",
                            "label":  "Amount payable under agreement"
                            }
                        }
                    },
                "localname":  "AmountPayableUnderAgreement",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_AugustTwoThousandTwentyOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "August Two Thousand Twenty One [Member]",
                            "label":  "August Two Thousand Twenty One [Member]"
                            }
                        }
                    },
                "localname":  "AugustTwoThousandTwentyOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_BoardOfDirectorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Board of Directors [Member]",
                            "label":  "Board of Directors [Member]"
                            }
                        }
                    },
                "localname":  "BoardOfDirectorsMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_BudgetReserchExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Budget reaserch expenses.",
                            "label":  "[custom:BudgetReserchExpense-0]"
                            }
                        }
                    },
                "localname":  "BudgetReserchExpense",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExtended":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrant shares extended.",
                            "label":  "Warrant to purchase common stock"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExtended",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_CommitmentDateFairValueOfCommonStock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commitment date fair value of common stock.",
                            "label":  "Commitment date fair value of common stock"
                            }
                        }
                    },
                "localname":  "CommitmentDateFairValueOfCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "CLCS_CommonStockAccruedDividendIssued":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock accrued dividends issued.",
                            "label":  "Accrued dividend issued"
                            }
                        }
                    },
                "localname":  "CommonStockAccruedDividendIssued",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_CommonStockBasedCompensation":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock based compensation.",
                            "label":  "CommonStockBasedCompensation",
                            "verboseLabel":  "Common stock"
                            }
                        }
                    },
                "localname":  "CommonStockBasedCompensation",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_CommonStockIssuedInSatisfactionOfAccruedCompensation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock issued in satisfaction of accrued compensation.",
                            "label":  "CommonStockIssuedInSatisfactionOfAccruedCompensation",
                            "verboseLabel":  "Common stock issued in satisfaction of accrued compensation"
                            }
                        }
                    },
                "localname":  "CommonStockIssuedInSatisfactionOfAccruedCompensation",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_CommonStockSharesIssuedInSatisfactionOfAccruedCompensation":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock shares issued in satisfaction of accrued compensation.",
                            "label":  "Common stock issued in satisfaction of accrued compensation, shares"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssuedInSatisfactionOfAccruedCompensation",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_CommonStockValueIssuedInSatisfactionOfAccruedCompensation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common sock value issued in satisfaction of accrued compensation.",
                            "label":  "Common stock issued in satisfaction of accrued compensation"
                            }
                        }
                    },
                "localname":  "CommonStockValueIssuedInSatisfactionOfAccruedCompensation",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ConsultantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Consultant [Member]",
                            "label":  "Consultant [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConsultingServicesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Consulting Services [Member]",
                            "label":  "Consulting Services [Member]"
                            }
                        }
                    },
                "localname":  "ConsultingServicesMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConversionOfAccruedInterestInCommonStockShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Conversion of accrued interest in common stock shares.",
                            "label":  "Conversion of accrued interest in common stock, shares"
                            }
                        }
                    },
                "localname":  "ConversionOfAccruedInterestInCommonStockShares",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertiblePreferredStockAndCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Conversion of convertible notes payable and accrued interest into series C convertible preferred.",
                            "label":  "Conversion of convertible notes payable and accrued interest into Series C Convertible Preferred Stock and common stock"
                            }
                        }
                    },
                "localname":  "ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertiblePreferredStockAndCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertibleSharesPreferredStockAndCommonStock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Conversion of convertible notes payable and accrued interest into series C convertible shares preferred stock and common stock.",
                            "label":  "Conversion of convertible notes payable and notes payable and accrued interest into Series C Convertible Preferred Stock and common stock, shares"
                            }
                        }
                    },
                "localname":  "ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertibleSharesPreferredStockAndCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCPreferredStockAndCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Conversion of convertible notes payable and accrued interest into Series C Preferred Stock and common stock.",
                            "label":  "Conversion of convertible notes payable and accrued interest into Series C Preferred Stock and common stock"
                            }
                        }
                    },
                "localname":  "ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCPreferredStockAndCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ConversionOfConvertiblePreferredStockIntoCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Conversion of convertible preferred stock into common stock.",
                            "label":  "ConversionOfConvertiblePreferredStockIntoCommonStock",
                            "verboseLabel":  "Conversion of Series C Convertible Preferred Stock into common stock"
                            }
                        }
                    },
                "localname":  "ConversionOfConvertiblePreferredStockIntoCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ConversionOfSeriesCConvertiblePreferredStockIntoCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Conversion of Series C Convertible Preferred Stock into common stock.",
                            "label":  "Conversion of Series C Convertible Preferred Stock into common stock"
                            }
                        }
                    },
                "localname":  "ConversionOfSeriesCConvertiblePreferredStockIntoCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ConversionOfSharesSeriesCConvertiblePreferredStockIntoCommonStock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Conversion of shares series C convertible preferred stock into common stock.",
                            "label":  "Conversion of Series C Convertible Preferred Stock into common stock, shares"
                            }
                        }
                    },
                "localname":  "ConversionOfSharesSeriesCConvertiblePreferredStockIntoCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_ConvertibleInstrumentsPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Instruments [Policy Text Block]",
                            "label":  "Convertible Instruments"
                            }
                        }
                    },
                "localname":  "ConvertibleInstrumentsPolicyTextBlock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "CLCS_ConvertibleNoteIssuedOnJulyTwentyNineTwentyTwentyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Note Issued On July 29, 2020 [Member]",
                            "label":  "Convertible Note Issued On July 29, 2020 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNoteIssuedOnJulyTwentyNineTwentyTwentyMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNoteMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Note [Member]",
                            "label":  "Convertible Note [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNoteMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotePurchaseAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Note Purchase Agreements [Member]",
                            "label":  "Convertible Note Purchase Agreements [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotePurchaseAgreementsMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedBetweenDecemberElevenandDecemberFifteenTwentyTwentyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued Between December 11 and December 15, 2020 [Member]",
                            "label":  "Convertible Notes Issued Between December 11 and December 15, 2020 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedBetweenDecemberElevenandDecemberFifteenTwentyTwentyMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedBetweenJulyEightandDecemberFifteenTwentyTwentyOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued Between July 8 and December 15, 2021 [Member]",
                            "label":  "Convertible Notes Issued Between July 8 and December 15, 2021 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedBetweenJulyEightandDecemberFifteenTwentyTwentyOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedBetweenOctoberElevenandOctoberFifteenTwentyTwentyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued Between October 11 and October 15, 2020 [Member]",
                            "label":  "Convertible Notes Issued Between October 11 and October 15, 2020 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedBetweenOctoberElevenandOctoberFifteenTwentyTwentyMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedOnJuly24TwoThousandFifteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued On July 24, 2015 [Member]",
                            "label":  "Convertible Notes Issued On July 24, 2015 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedOnJuly24TwoThousandFifteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedOnMay18TwoThousandSeventeenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued On May 18, 2017 [Member]",
                            "label":  "Convertible Notes Issued On May 18, 2017 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedOnMay18TwoThousandSeventeenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedOnMayEighteenTwoThousandSeventeenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued on May 18, 2017 [Member]",
                            "label":  "Convertible Notes Issued on May 18, 2017 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedOnMayEighteenTwoThousandSeventeenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedOnOctober7TwoThousandFifteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued On October 7, 2015 [Member]",
                            "label":  "Convertible Notes Issued On October 7, 2015 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedOnOctober7TwoThousandFifteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesIssuedOnOctoberTwentyEightTwoThousandNineteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Issued on October 29, 2019 [Member]",
                            "label":  "Convertible Notes Issued on October 29, 2019 [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesIssuedOnOctoberTwentyEightTwoThousandNineteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetailsParenthetical"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes [Member]",
                            "label":  "Convertible Notes [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesPayableCurrentNet":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Payable Current Portion Net Of Debt Discount.",
                            "label":  "Convertible notes payable, net of debt discount of $71,124 and $82,403 as of December 31, 2021 and 2020, respectively"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableCurrentNet",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ConvertibleNotesPayableDueToRelatedPartiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Payable Due To Related Parties [Table Text Block]",
                            "label":  "Schedule of Convertible Notes Payable Due to Related Parties"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableDueToRelatedPartiesTableTextBlock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "CLCS_ConvertibleNotesPayableNewNoteMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Payable New Note [Member]",
                            "label":  "Convertible Notes Payable New Note [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableNewNoteMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesPayableOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Payable One [Member]",
                            "label":  "Convertible Notes Payable One [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesPayableRelatedPartiesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Payable Related Parties [Member]",
                            "label":  "Convertible Notes Payable Related Parties [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableRelatedPartiesMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertibleNotesPayableTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible Notes Payable Two [Member]",
                            "label":  "Convertible Notes Payable Two [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableTwoMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ConvertiblePreferredStockSharesDesignated":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Convertible preferred stock shares designated.",
                            "label":  "Preferred stock, shares designated"
                            }
                        }
                    },
                "localname":  "ConvertiblePreferredStockSharesDesignated",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_CourtOfficerMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Court Officer [Member]",
                            "label":  "Court Officer [Member]"
                            }
                        }
                    },
                "localname":  "CourtOfficerMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_DecemberOneTwoThousandTwentyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "December 1, 2020 [Member]",
                            "label":  "December 1, 2020 [Member]"
                            }
                        }
                    },
                "localname":  "DecemberOneTwoThousandTwentyMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_DecemberThirtyFirstTwoThousandTwentyOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "December Thirty First Two Thousand Twenty One [Member]",
                            "label":  "December Thirty First Two Thousand Twenty One [Member]"
                            }
                        }
                    },
                "localname":  "DecemberThirtyFirstTwoThousandTwentyOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_DerivativeLiabilityMeasurementInputExpectedTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Derivative Liability Measurement Input Expected Term.",
                            "label":  "Derivative liability, expected term (years)"
                            }
                        }
                    },
                "localname":  "DerivativeLiabilityMeasurementInputExpectedTerm",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "CLCS_DescriptionOfAmountPayableForResearch":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of amount payable for research.",
                            "label":  "[custom:DescriptionOfAmountPayableForResearch]"
                            }
                        }
                    },
                "localname":  "DescriptionOfAmountPayableForResearch",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "CLCS_DescriptionOfWarrants":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of warrants.",
                            "label":  "Description of warrants"
                            }
                        }
                    },
                "localname":  "DescriptionOfWarrants",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "CLCS_DisclosureAccruedCompensationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accrued Compensation",
                            "verboseLabel":  "Schedule Of Accrued Compensation"
                            }
                        }
                    },
                "localname":  "DisclosureAccruedCompensationAbstract",
                "nsuri":  "http://cellsource.com/20211231",
                "xbrltype":  "stringItemType"
                },
            "CLCS_DividendsPreferredStockPaidinkindShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Dividends preferred stock paid in kind shares.",
                            "label":  "Payment of dividends in kind, shares"
                            }
                        }
                    },
                "localname":  "DividendsPreferredStockPaidinkindShares",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_ExercisePriceOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise Price One [Member]",
                            "label":  "Exercise Price One [Member]"
                            }
                        }
                    },
                "localname":  "ExercisePriceOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ExercisePriceThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise Price Three [Member]",
                            "label":  "Exercise Price Three [Member]"
                            }
                        }
                    },
                "localname":  "ExercisePriceThreeMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ExercisePriceTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise Price Two [Member]",
                            "label":  "Exercise Price Two [Member]"
                            }
                        }
                    },
                "localname":  "ExercisePriceTwoMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ExpectedVolatilityRate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expected volatility rate.",
                            "label":  "Expected volatility rate"
                            }
                        }
                    },
                "localname":  "ExpectedVolatilityRate",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "CLCS_FairValueInputsMeasuredOnRecurringBasisBeginningBalance":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value inputs measured on recurring basis beginning balance.",
                            "label":  "FairValueInputsMeasuredOnRecurringBasisBeginningBalance",
                            "periodStartLabel":  "Beginning balance"
                            }
                        }
                    },
                "localname":  "FairValueInputsMeasuredOnRecurringBasisBeginningBalance",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_FairValueInputsMeasuredOnRecurringBasisEndingBalance":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value inputs measured on recurring basis ending balance.",
                            "label":  "FairValueInputsMeasuredOnRecurringBasisEndingBalance",
                            "periodEndLabel":  "Ending balance"
                            }
                        }
                    },
                "localname":  "FairValueInputsMeasuredOnRecurringBasisEndingBalance",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_FairValueOfAccruedLoanObligations":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value of loan obligation.",
                            "label":  "FairValueOfAccruedLoanObligations",
                            "verboseLabel":  "Accrued interest - related parties"
                            }
                        }
                    },
                "localname":  "FairValueOfAccruedLoanObligations",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_FairValueOfOption":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value of option.",
                            "label":  "Fair value of option"
                            }
                        }
                    },
                "localname":  "FairValueOfOption",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_FinancingOfDirectorsAndOfficersInsurance":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Financing of Directors and Officer\u2019s insurance.",
                            "label":  "Financing of Directors and Officer\u2019s insurance"
                            }
                        }
                    },
                "localname":  "FinancingOfDirectorsAndOfficersInsurance",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_FromJanuaryOneTwoThousandNineteenToDecemberThirtyOneTwoThousandTwentyOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "From January 1, 2019 to December 31, 2021 [Member]",
                            "label":  "From January 1, 2019 to December 31, 2021 [Member]"
                            }
                        }
                    },
                "localname":  "FromJanuaryOneTwoThousandNineteenToDecemberThirtyOneTwoThousandTwentyOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_GainOnExchangeOfAccruedInterestForCommonStock":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        },
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gain on exchange of accrued interest for common stock.",
                            "label":  "Gain on exchange of accrued interest for common stock",
                            "negatedLabel":  "Gain on exchange of accrued interest for common stock"
                            }
                        }
                    },
                "localname":  "GainOnExchangeOfAccruedInterestForCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows",
                    "http://cellsource.com/role/StatementsOfOperations",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_GainOnForgivenessOfAccruedInterest":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        },
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gain on Forgiveness of accrued interest.",
                            "label":  "Gain on forgiveness of accrued interest",
                            "negatedLabel":  "Gain on forgiveness of accrued interest"
                            }
                        }
                    },
                "localname":  "GainOnForgivenessOfAccruedInterest",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfCashFlows",
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_GrossProceedsFromConvertibleDebt":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross Proceeds from Convertible Debt.",
                            "label":  "Gross proceeds from convertible debt"
                            }
                        }
                    },
                "localname":  "GrossProceedsFromConvertibleDebt",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IncomeTaxExpenseBenefitValuationAllowance":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Change in valuation allowance.",
                            "label":  "IncomeTaxExpenseBenefitValuationAllowance",
                            "negatedLabel":  "Change in valuation allowance"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefitValuationAllowance",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IncreaseDecreaseInAccruedLiabilitiesRelatedParties":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  16.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase Decrease in accrued liabilities related parties.",
                            "label":  "IncreaseDecreaseInAccruedLiabilitiesRelatedParties",
                            "verboseLabel":  "Accrued expenses - related parties"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilitiesRelatedParties",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IncreasedecreaseinaccruedInterestRelatedParties":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  18.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase decrease in accrued interest related parties.",
                            "label":  "IncreasedecreaseinaccruedInterestRelatedParties",
                            "verboseLabel":  "Accrued interest - related parties"
                            }
                        }
                    },
                "localname":  "IncreasedecreaseinaccruedInterestRelatedParties",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_InterestExpenseRelatedParties":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest Expense Related Parties.",
                            "label":  "InterestExpenseRelatedParties",
                            "negatedLabel":  "Interest expense - related parties"
                            }
                        }
                    },
                "localname":  "InterestExpenseRelatedParties",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IsraeliShekelMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Israeli Shekel [Member]",
                            "label":  "Israeli Shekel [Member]"
                            }
                        }
                    },
                "localname":  "IsraeliShekelMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_IssuanceOfCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common stock.",
                            "label":  "Issuance of common stock"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfCommonStockAsDebtDiscountInConnection":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common stock as debt discount in in connection.",
                            "label":  "Issuance of common stock as debt discount in in connection with extension of notes payable"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStockAsDebtDiscountInConnection",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfCommonStockInConnectionWithWarrantExercise":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common stock in connection with warrant exercise.",
                            "label":  "Issuance of common stock in connection with warrant exercise"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStockInConnectionWithWarrantExercise",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfCommonStockInExchangeOfAccruedInterest":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common stock in exchange of accrued interest.",
                            "label":  "Issuance of common stock in exchange of accrued interest"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStockInExchangeOfAccruedInterest",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfCommonStockInExchangeOfAccruedInterestShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common stock in exchange of accrued interest shares.",
                            "label":  "Issuance of common stock in exchange of accrued interest, shares"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStockInExchangeOfAccruedInterestShares",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_IssuanceOfCommonStockPursuantToCashlessWarrantExercise":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common stock pursuant to cashless warrant exercise.",
                            "label":  "IssuanceOfCommonStockPursuantToCashlessWarrantExercise",
                            "verboseLabel":  "Issuance of common stock pursuant to cashless warrant exercise"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStockPursuantToCashlessWarrantExercise",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfCommonStockSharesInConnectionWithWarrantExercise":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of common stock shares in connection with warrant exercise.",
                            "label":  "Issuance of common stock in connection with warrant exercise, shares"
                            }
                        }
                    },
                "localname":  "IssuanceOfCommonStockSharesInConnectionWithWarrantExercise",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_IssuanceOfPlacementAgentWarrants":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of placement agent warrants.",
                            "label":  "Issuance of placement agent warrants"
                            }
                        }
                    },
                "localname":  "IssuanceOfPlacementAgentWarrants",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfWarrants":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of warrants.",
                            "label":  "Issuance of warrants"
                            }
                        }
                    },
                "localname":  "IssuanceOfWarrants",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfWarrantsInConnectionWithIssuanceOfAdvancePayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of warrants in connection with issuance of advance payable.",
                            "label":  "Issuance of warrants in connection with issuance of advance payable"
                            }
                        }
                    },
                "localname":  "IssuanceOfWarrantsInConnectionWithIssuanceOfAdvancePayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfWarrantsInConnectionWithIssuanceOfNotesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of warrants in connection with the issuance of notes payable.",
                            "label":  "Issuance of warrants in connection with the issuance of notes payable"
                            }
                        }
                    },
                "localname":  "IssuanceOfWarrantsInConnectionWithIssuanceOfNotesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_IssuanceOfWarrantsInSatisfactionOfAccruedInterest":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Issuance of warrants in satisfaction of accrued interest.",
                            "label":  "Issuance of warrants in satisfaction of accrued interest"
                            }
                        }
                    },
                "localname":  "IssuanceOfWarrantsInSatisfactionOfAccruedInterest",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_JanuaryFiveTwoThousandTwentyOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "January five two thousand twenty one [Member]",
                            "label":  "January Five Two Thousand Twenty One [Member]"
                            }
                        }
                    },
                "localname":  "JanuaryFiveTwoThousandTwentyOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_LoanPenaltiesAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Loan penaltiy.",
                            "label":  "Loan amount"
                            }
                        }
                    },
                "localname":  "LoanPenaltiesAmount",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_MDAndersonMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "MD Anderson [Member]",
                            "label":  "MD Anderson [Member]"
                            }
                        }
                    },
                "localname":  "MDAndersonMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_MDAndersonSponsoredResearchAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "MD Anderson Sponsored Research Agreements [Member]",
                            "label":  "MD Anderson Sponsored Research Agreements [Member]"
                            }
                        }
                    },
                "localname":  "MDAndersonSponsoredResearchAgreementsMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_MrVerstraeteMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Mr Verstraete [Member]",
                            "label":  "Mr Verstraete [Member]"
                            }
                        }
                    },
                "localname":  "MrVerstraeteMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_MsSoaveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Ms.  Soave [Member]",
                            "label":  "Ms.  Soave [Member]"
                            }
                        }
                    },
                "localname":  "MsSoaveMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NoteIssuedOnFebruaryTwentySixTwoThousandEightteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Note Issued on February 26, 2018 [Member]",
                            "label":  "Note Issued on February 26, 2018 [Member]"
                            }
                        }
                    },
                "localname":  "NoteIssuedOnFebruaryTwentySixTwoThousandEightteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NoteIssuedOnJulyTwentyNineTwoThousandNinteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Note Issued on July 29, 2019 [Member]",
                            "label":  "Note Issued on July 29, 2019 [Member]"
                            }
                        }
                    },
                "localname":  "NoteIssuedOnJulyTwentyNineTwoThousandNinteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NoteIssuedOnMay10TwoThousandSixteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Note Issued on May 10, 2016\t[Member]",
                            "label":  "Note Issued on May 10, 2016 [Member]"
                            }
                        }
                    },
                "localname":  "NoteIssuedOnMay10TwoThousandSixteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NoteIssuedOnMay15TwoThousandFifteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Note Issued on May 15, 2015 [Member]",
                            "label":  "Note Issued on May 15, 2015 [Member]"
                            }
                        }
                    },
                "localname":  "NoteIssuedOnMay15TwoThousandFifteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NoteIssuedOnNovemberTwentySixTwoThousandFourteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Note Issued on November 26, 2014 [Member]",
                            "label":  "Note Issued on November 26, 2014 [Member]"
                            }
                        }
                    },
                "localname":  "NoteIssuedOnNovemberTwentySixTwoThousandFourteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NoteholderMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noteholder [Member]",
                            "label":  "Noteholder [Member]"
                            }
                        }
                    },
                "localname":  "NoteholderMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NotesIssuedOnJuly202015TwoThousandFifteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Note Issued on July 20, 2015 [Member]",
                            "label":  "Note Issued on July 20, 2015 [Member]"
                            }
                        }
                    },
                "localname":  "NotesIssuedOnJuly202015TwoThousandFifteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NotesIssuedOnMarch26TwoThousandFifteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Notes Issued on March 26, 2020 [Member]",
                            "label":  "Notes Issued on March 26, 2020 [Member]"
                            }
                        }
                    },
                "localname":  "NotesIssuedOnMarch26TwoThousandFifteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NotesIssuedOnVariousDatesFromJuly20TwoThousandSixteenToOctober13TwoThousandSixteenMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Notes Issued on Various Dates from July 20, 2016 to October 13, 2016\t[Member]",
                            "label":  "Notes Issued on Various Dates from July 20, 2016 to October 13, 2016 [Member]"
                            }
                        }
                    },
                "localname":  "NotesIssuedOnVariousDatesFromJuly20TwoThousandSixteenToOctober13TwoThousandSixteenMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_NotesPayableDueToRelatedPartiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Notes Payable Due To Related Parties [Table Text Block]",
                            "label":  "Schedule of Notes Payable Due to Related Parties"
                            }
                        }
                    },
                "localname":  "NotesPayableDueToRelatedPartiesTableTextBlock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "CLCS_NotesPayableMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Notes Payable [Member]",
                            "label":  "Notes Payable [Member]"
                            }
                        }
                    },
                "localname":  "NotesPayableMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_OperatingLossCarryforwardsNotSubjectToExpiration":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating loss carryforwards not subject to expiration.",
                            "label":  "Operating loss carryforwards not subject to expiration"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwardsNotSubjectToExpiration",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_OperatingLossCarryforwardsSubjectToExpiration":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating loss carryforwards subject to expiration",
                            "label":  "Operating loss carryforwards subject to expiration"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwardsSubjectToExpiration",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_OptionPricingMethodMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Option Pricing Method [Member]",
                            "label":  "Option Pricing Method [Member]"
                            }
                        }
                    },
                "localname":  "OptionPricingMethodMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_OptionsPricingMethodDiscountRate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Options pricing method discount rate.",
                            "label":  "Options pricing method discount rate"
                            }
                        }
                    },
                "localname":  "OptionsPricingMethodDiscountRate",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "CLCS_OriginalIssueDiscountInConnectionWithConvertibleNotePayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Original issue discount in connection with convertible note payable.",
                            "label":  "Original issue discount in connection with convertible note payable"
                            }
                        }
                    },
                "localname":  "OriginalIssueDiscountInConnectionWithConvertibleNotePayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_PreferredStockPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Preferred Stock [Policy Text Block]",
                            "label":  "Preferred Stock"
                            }
                        }
                    },
                "localname":  "PreferredStockPolicyTextBlock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "CLCS_PrivatePlacementMemorandumMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Private Placement Memorandum [Member]",
                            "label":  "Private Placement Memorandum [Member]"
                            }
                        }
                    },
                "localname":  "PrivatePlacementMemorandumMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ProceedsFromAdvancesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Proceeds from advances payable.",
                            "label":  "ProceedsFromAdvancesPayable",
                            "verboseLabel":  "Proceeds from advances payable"
                            }
                        }
                    },
                "localname":  "ProceedsFromAdvancesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/AdvancesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_PromissoryNoteMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Promissory Note [Member]",
                            "label":  "Promissory Note [Member]"
                            }
                        }
                    },
                "localname":  "PromissoryNoteMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_PromissoryNoteOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Promissory Note 1 [Member]",
                            "label":  "Promissory Note 1 [Member]"
                            }
                        }
                    },
                "localname":  "PromissoryNoteOneMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ReclassificationOfDerivativeLiabilities":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reclassification of derivative liabilities.",
                            "label":  "ReclassificationOfDerivativeLiabilities",
                            "verboseLabel":  "Reclassification of derivative liabilities to equity"
                            }
                        }
                    },
                "localname":  "ReclassificationOfDerivativeLiabilities",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ReclassificationOfDerivativeLiabilitiesEquity":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reclassification of derivative liabilities equity.",
                            "label":  "ReclassificationOfDerivativeLiabilitiesEquity",
                            "verboseLabel":  "Reclassification of derivative liabilities to equity"
                            }
                        }
                    },
                "localname":  "ReclassificationOfDerivativeLiabilitiesEquity",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ReclassificationOfDerivativeLiabilitiesToEquities":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reclassification of derivative liabilities to equities.",
                            "label":  "ReclassificationOfDerivativeLiabilitiesToEquities",
                            "verboseLabel":  "Reclassification of derivative liabilities to equity"
                            }
                        }
                    },
                "localname":  "ReclassificationOfDerivativeLiabilitiesToEquities",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ReclassificationOfDerivativeLiabilitiesToEquity":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reclassification of derivative liabilities to equity.",
                            "label":  "Reclassification of derivative liabilities to equity"
                            }
                        }
                    },
                "localname":  "ReclassificationOfDerivativeLiabilitiesToEquity",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ReclassificationOfDerivativeLiabilitiesToEquityOne":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reclassification of derivative liabilities to equity one.",
                            "label":  "ReclassificationOfDerivativeLiabilitiesToEquityOne",
                            "verboseLabel":  "Reclassification of derivative liabilities to equity"
                            }
                        }
                    },
                "localname":  "ReclassificationOfDerivativeLiabilitiesToEquityOne",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ReclassificationOfDerivativeLiabilitiesToEquityTen":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reclassification of derivative liabilities to equity ten.",
                            "label":  "ReclassificationOfDerivativeLiabilitiesToEquityTen",
                            "verboseLabel":  "Reclassification of derivative liabilities to equity"
                            }
                        }
                    },
                "localname":  "ReclassificationOfDerivativeLiabilitiesToEquityTen",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_RepaymentOfAdvancesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Repayment of advances payable.",
                            "label":  "Repayment of cash in advance"
                            }
                        }
                    },
                "localname":  "RepaymentOfAdvancesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/AdvancesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_RepaymentOfConvertibleNotePayableAndAccruedInterestByThirdParty":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Repayment of convertible note payable and accrued interest by third party.",
                            "label":  "Repayment of convertible note payable and accrued interest by third party"
                            }
                        }
                    },
                "localname":  "RepaymentOfConvertibleNotePayableAndAccruedInterestByThirdParty",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ResearchAndDevelopmentRelatedParty":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Research and Developement related party.",
                            "label":  "Research and development - related party"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentRelatedParty",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_SeriesAConvertiblePreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Series A Convertible Preferred Stock [Member]",
                            "label":  "Series A Convertible Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "SeriesAConvertiblePreferredStockMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_SeriesCConvertiblePreferredStockIssuedInConnectionWithLossOnExtinguishmentOfNotesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Series C convertible preferred stock issued in connection with loss on extinguishment of notes payable.",
                            "label":  "Series C Convertible Preferred Stock issued in connection with loss on extinguishment of notes payable"
                            }
                        }
                    },
                "localname":  "SeriesCConvertiblePreferredStockIssuedInConnectionWithLossOnExtinguishmentOfNotesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_SeriesCConvertiblePreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Series C Convertible Preferred Stock [Member]",
                            "label":  "Series C Convertible Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "SeriesCConvertiblePreferredStockMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of warrant exercisable.",
                            "label":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
                            "periodEndLabel":  "Number of Warrants, Exercisable"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWarrantDownRoundAdjustment":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award non option equity instruments warrant down round adjustment.",
                            "label":  "Number of Warrants, Warrant Down Round Adjustment"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWarrantDownRoundAdjustment",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award Non-Options Exercisable Weighted Average Exercise Price.",
                            "label":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice",
                            "periodEndLabel":  "Weighted Average Exercise Price, Exercisable"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "CLCS_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock warrants into shares.",
                            "label":  "Weighted Average Exercise Price, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "CLCS_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpiredCacelledWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award Non-Options Expired Weighted Average Exercise Price.",
                            "label":  "Weighted Average Exercise Price, Expired/Cacelled"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpiredCacelledWeightedAverageExercisePrice",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "CLCS_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrant.",
                            "label":  "Weighted Average Exercise Price, Isuued"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "CLCS_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsWarrantDownRoundAdjustmentWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by warrant down round adjustmentof warrant.",
                            "label":  "Weighted Average Exercise Price, Warrant Down Round Adjustment"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsWarrantDownRoundAdjustmentWeightedAverageExercisePrice",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "CLCS_ShareBasedCompensationIncludedInStockholdersDeficiency":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation included in stockholders deficiency.",
                            "label":  "[custom:ShareBasedCompensationIncludedInStockholdersDeficiency]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationIncludedInStockholdersDeficiency",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award Non-Options Exercisable Intrinsic Value.",
                            "label":  "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1",
                            "periodEndLabel":  "Intrinsic Value, Exercisable, Ending"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award Non-Options Exercisable Weighted Average Remaining Contractual Term.",
                            "label":  "Weighted Average Remaining Life (In Years), Exercisable"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "CLCS_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for warrant awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Weighted Average Remaining Life (In Years), Outstanding"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "CLCS_SoaveNoteMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Soave Note [Member]",
                            "label":  "Soave Note [Member]"
                            }
                        }
                    },
                "localname":  "SoaveNoteMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_SponsoredResearchAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sponsored Research Agreement [Member]",
                            "label":  "Sponsored Research Agreement [Member]"
                            }
                        }
                    },
                "localname":  "SponsoredResearchAgreementMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_StockIssuedDuringConvertiblePreferredStockAndWarrantsIssuedInConnectionWithLossOnExtinguishmentOfNotesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during convertible preferred stock and warrants issued in connection with loss on extinguishment of notes payable.",
                            "label":  "Series C Convertible Preferred Stock and warrants issued in connection with loss on extinguishment of notes payable"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringConvertiblePreferredStockAndWarrantsIssuedInConnectionWithLossOnExtinguishmentOfNotesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_StockIssuedDuringConvertiblePreferredStockAndWarrantsIssuedInConnectionWithSharesLossOnExtinguishmentOfNotesPayable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during convertible preferred stock and warrants issued in connection with shares loss on extinguishment of notes payable.",
                            "label":  "Series C Convertible Preferred Stock and warrants issued in connection with loss on extinguishment of notes payable, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringConvertiblePreferredStockAndWarrantsIssuedInConnectionWithSharesLossOnExtinguishmentOfNotesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_StockIssuedDuringPeriodForAccruedInterestShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during accrued interest shares.",
                            "label":  "Stock issued during period for accrued interest, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodForAccruedInterestShares",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_StockIssuedDuringPeriodForAccruedInterestValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Issued During Period for Accrued Interest Value.",
                            "label":  "Stock issued during period for accrued interest, value"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodForAccruedInterestValue",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_StockIssuedDuringPeriodForWarrantExerciseShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Issued During Period for Warrant Exercise Shares.",
                            "label":  "Stock issued during period for warrant exercise, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodForWarrantExerciseShares",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_StockOptionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Options [Member]",
                            "label":  "Stock Options [Member]"
                            }
                        }
                    },
                "localname":  "StockOptionsMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails",
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_StockOptionsToPurchaseCommonStock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock options to purchase common stock",
                            "label":  "Vested stock option granted, shares"
                            }
                        }
                    },
                "localname":  "StockOptionsToPurchaseCommonStock",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "CLCS_StockbasedCompensationWarrants":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock based compensation warrants.",
                            "label":  "Stock-based compensation - warrants"
                            }
                        }
                    },
                "localname":  "StockbasedCompensationWarrants",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_ThreeConvertibleNotesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Three Convertible Notes [Member]",
                            "label":  "Three Convertible Notes [Member]"
                            }
                        }
                    },
                "localname":  "ThreeConvertibleNotesMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_TwoConvertibleNotesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two Convertible Notes [Member]",
                            "label":  "Two Convertible Notes [Member]"
                            }
                        }
                    },
                "localname":  "TwoConvertibleNotesMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_WarrantModificationExpense":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrant modification expense.",
                            "label":  "Warrant modification expense",
                            "verboseLabel":  "Warrant modification expense."
                            }
                        }
                    },
                "localname":  "WarrantModificationExpense",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_WarrantsAndConversionOptionsIssuedInConnectionWithIssuanceAndExtensionOfNotesPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrants and conversion options issued in connection with issuance and extension of notes payable.",
                            "label":  "Warrants and conversion options issued in connection with issuance and extension of notes payable"
                            }
                        }
                    },
                "localname":  "WarrantsAndConversionOptionsIssuedInConnectionWithIssuanceAndExtensionOfNotesPayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_WarrantsBasedCompensation":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrants based compensation.",
                            "label":  "WarrantsBasedCompensation",
                            "verboseLabel":  "Warrants"
                            }
                        }
                    },
                "localname":  "WarrantsBasedCompensation",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_WarrantsIssuedInConnectionWithIssuanceOfAdvancePayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrants issued in connection with issuance of advance payable.",
                            "label":  "Warrants issued in connection with issuance of advance payable"
                            }
                        }
                    },
                "localname":  "WarrantsIssuedInConnectionWithIssuanceOfAdvancePayable",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_WarrantsIssuedInSatisfactionOfAccruedInterest":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrants issued in satisfaction of accrued interest.",
                            "label":  "Warrants issued in satisfaction of accrued interest"
                            }
                        }
                    },
                "localname":  "WarrantsIssuedInSatisfactionOfAccruedInterest",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_WarrantsModificationExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrants Modification Expense.",
                            "label":  "Warrants modification expense"
                            }
                        }
                    },
                "localname":  "WarrantsModificationExpense",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_WeightedAveragesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Averages [Member]",
                            "label":  "Weighted Averages [Member]"
                            }
                        }
                    },
                "localname":  "WeightedAveragesMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_WorkingCapitalSurplusDeficiency":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Working capital surplus deficiency.",
                            "label":  "Working capital deficiency"
                            }
                        }
                    },
                "localname":  "WorkingCapitalSurplusDeficiency",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "CLCS_YedaMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Yeda [Member].",
                            "label":  "Yeda [Member]"
                            }
                        }
                    },
                "localname":  "YedaMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "CLCS_YedaResearchAndLicenseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Yeda Research and License Agreement [Member]",
                            "label":  "Yeda Research and License Agreement [Member]"
                            }
                        }
                    },
                "localname":  "YedaResearchAndLicenseAgreementMember",
                "nsuri":  "http://cellsource.com/20211231",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_AmendmentDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of changes contained within amended document.",
                            "label":  "Amendment Description"
                            }
                        }
                    },
                "localname":  "AmendmentDescription",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AnnualInformationForm":  {
                "auth_ref":  [
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
                            "label":  "Annual Information Form"
                            }
                        }
                    },
                "localname":  "AnnualInformationForm",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AuditedAnnualFinancialStatements":  {
                "auth_ref":  [
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
                            "label":  "Audited Annual Financial Statements"
                            }
                        }
                    },
                "localname":  "AuditedAnnualFinancialStatements",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AuditorFirmId":  {
                "auth_ref":  [
                    "r528",
                    "r530",
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "PCAOB issued Audit Firm Identifier",
                            "label":  "Auditor Firm ID"
                            }
                        }
                    },
                "localname":  "AuditorFirmId",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "nonemptySequenceNumberItemType"
                },
            "dei_AuditorLocation":  {
                "auth_ref":  [
                    "r528",
                    "r530",
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Auditor Location"
                            }
                        }
                    },
                "localname":  "AuditorLocation",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "internationalNameItemType"
                },
            "dei_AuditorName":  {
                "auth_ref":  [
                    "r528",
                    "r530",
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Auditor Name"
                            }
                        }
                    },
                "localname":  "AuditorName",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "internationalNameItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CountryRegion":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Region code of country",
                            "label":  "Country Region"
                            }
                        }
                    },
                "localname":  "CountryRegion",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentAccountingStandard":  {
                "auth_ref":  [
                    "r530"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S.  GAAP', 'International Financial Reporting Standards', or 'Other'.",
                            "label":  "Document Accounting Standard"
                            }
                        }
                    },
                "localname":  "DocumentAccountingStandard",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "accountingStandardItemType"
                },
            "dei_DocumentAnnualReport":  {
                "auth_ref":  [
                    "r528",
                    "r530",
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an annual report.",
                            "label":  "Document Annual Report"
                            }
                        }
                    },
                "localname":  "DocumentAnnualReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentPeriodStartDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The start date of the period covered in the document, in YYYY-MM-DD format.",
                            "label":  "Document Period Start Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodStartDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r529"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentRegistrationStatement":  {
                "auth_ref":  [
                    "r517"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a registration statement.",
                            "label":  "Document Registration Statement"
                            }
                        }
                    },
                "localname":  "DocumentRegistrationStatement",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentShellCompanyEventDate":  {
                "auth_ref":  [
                    "r530"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date of event requiring a shell company report.",
                            "label":  "Document Shell Company Event Date"
                            }
                        }
                    },
                "localname":  "DocumentShellCompanyEventDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentShellCompanyReport":  {
                "auth_ref":  [
                    "r530"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
                            "label":  "Document Shell Company Report"
                            }
                        }
                    },
                "localname":  "DocumentShellCompanyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r532"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_DocumentsIncorporatedByReferenceTextBlock":  {
                "auth_ref":  [
                    "r520"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Documents incorporated by reference.",
                            "label":  "Documents Incorporated by Reference"
                            }
                        }
                    },
                "localname":  "DocumentsIncorporatedByReferenceTextBlock",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine2":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 2 such as Street or Suite number",
                            "label":  "Entity Address, Address Line Two"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine2",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine3":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 3 such as an Office Park",
                            "label":  "Entity Address, Address Line Three"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine3",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCountry":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "ISO 3166-1 alpha-2 country code.",
                            "label":  "Entity Address, Country"
                            }
                        }
                    },
                "localname":  "EntityAddressCountry",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "countryCodeItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityBankruptcyProceedingsReportingCurrent":  {
                "auth_ref":  [
                    "r523"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
                            "label":  "Entity Bankruptcy Proceedings, Reporting Current"
                            }
                        }
                    },
                "localname":  "EntityBankruptcyProceedingsReportingCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r519"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r519"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityExTransitionPeriod":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
                            "label":  "Elected Not To Use the Extended Transition Period"
                            }
                        }
                    },
                "localname":  "EntityExTransitionPeriod",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r519"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r540"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityPrimarySicNumber":  {
                "auth_ref":  [
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary Standard Industrial Classification (SIC) Number for the Entity.",
                            "label":  "Entity Primary SIC Number"
                            }
                        }
                    },
                "localname":  "EntityPrimarySicNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "sicNumberItemType"
                },
            "dei_EntityPublicFloat":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
                            "label":  "Entity Public Float"
                            }
                        }
                    },
                "localname":  "EntityPublicFloat",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r519"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r519"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r519"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r519"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_EntityVoluntaryFilers":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
                            "label":  "Entity Voluntary Filers"
                            }
                        }
                    },
                "localname":  "EntityVoluntaryFilers",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "auth_ref":  [
                    "r541"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
                            "label":  "Entity Well-known Seasoned Issuer"
                            }
                        }
                    },
                "localname":  "EntityWellKnownSeasonedIssuer",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_Extension":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Extension number for local phone number.",
                            "label":  "Extension"
                            }
                        }
                    },
                "localname":  "Extension",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_IcfrAuditorAttestationFlag":  {
                "auth_ref":  [
                    "r528",
                    "r530",
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ICFR Auditor Attestation Flag"
                            }
                        }
                    },
                "localname":  "IcfrAuditorAttestationFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_NoTradingSymbolFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a security having no trading symbol.",
                            "label":  "No Trading Symbol Flag"
                            }
                        }
                    },
                "localname":  "NoTradingSymbolFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "trueItemType"
                },
            "dei_OtherReportingStandardItemNumber":  {
                "auth_ref":  [
                    "r530"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
                            "label":  "Other Reporting Standard Item Number"
                            }
                        }
                    },
                "localname":  "OtherReportingStandardItemNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "otherReportingStandardItemNumberItemType"
                },
            "dei_PreCommencementIssuerTenderOffer":  {
                "auth_ref":  [
                    "r524"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
                            "label":  "Pre-commencement Issuer Tender Offer"
                            }
                        }
                    },
                "localname":  "PreCommencementIssuerTenderOffer",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_PreCommencementTenderOffer":  {
                "auth_ref":  [
                    "r525"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
                            "label":  "Pre-commencement Tender Offer"
                            }
                        }
                    },
                "localname":  "PreCommencementTenderOffer",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r518"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_Security12gTitle":  {
                "auth_ref":  [
                    "r522"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(g) registered security.",
                            "label":  "Title of 12(g) Security"
                            }
                        }
                    },
                "localname":  "Security12gTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r521"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_SecurityReportingObligation":  {
                "auth_ref":  [
                    "r526"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
                            "label":  "Security Reporting Obligation"
                            }
                        }
                    },
                "localname":  "SecurityReportingObligation",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "securityReportingObligationItemType"
                },
            "dei_SolicitingMaterial":  {
                "auth_ref":  [
                    "r527"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
                            "label":  "Soliciting Material"
                            }
                        }
                    },
                "localname":  "SolicitingMaterial",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "dei_WrittenCommunications":  {
                "auth_ref":  [
                    "r542"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
                            "label":  "Written Communications"
                            }
                        }
                    },
                "localname":  "WrittenCommunications",
                "nsuri":  "http://xbrl.sec.gov/dei/2021q4",
                "presentation":  [
                    "http://cellsource.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "srt_ChiefExecutiveOfficerMember":  {
                "auth_ref":  [
                    "r147"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Chief Executive Officer [Member]"
                            }
                        }
                    },
                "localname":  "ChiefExecutiveOfficerMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ConsolidatedEntitiesAxis":  {
                "auth_ref":  [
                    "r97",
                    "r186",
                    "r190",
                    "r195",
                    "r356",
                    "r357",
                    "r361",
                    "r362",
                    "r417",
                    "r513"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consolidated Entities [Axis]"
                            }
                        }
                    },
                "localname":  "ConsolidatedEntitiesAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ConsolidatedEntitiesDomain":  {
                "auth_ref":  [
                    "r97",
                    "r186",
                    "r190",
                    "r195",
                    "r356",
                    "r357",
                    "r361",
                    "r362",
                    "r417",
                    "r513"
                    ],
                "localname":  "ConsolidatedEntitiesDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_DirectorMember":  {
                "auth_ref":  [
                    "r147"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Director [Member]"
                            }
                        }
                    },
                "localname":  "DirectorMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r201",
                    "r242",
                    "r281",
                    "r282",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r454",
                    "r496",
                    "r497",
                    "r514",
                    "r515"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails",
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r201",
                    "r242",
                    "r281",
                    "r282",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r454",
                    "r496",
                    "r497",
                    "r514",
                    "r515"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails",
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r201",
                    "r242",
                    "r271",
                    "r281",
                    "r282",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r454",
                    "r496",
                    "r497",
                    "r514",
                    "r515"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails",
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r201",
                    "r242",
                    "r271",
                    "r281",
                    "r282",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r454",
                    "r496",
                    "r497",
                    "r514",
                    "r515"
                    ],
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails",
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RestatementAxis":  {
                "auth_ref":  [
                    "r1",
                    "r99",
                    "r100",
                    "r101",
                    "r102",
                    "r103",
                    "r104",
                    "r105",
                    "r106",
                    "r107",
                    "r109",
                    "r110",
                    "r111",
                    "r112",
                    "r113",
                    "r114",
                    "r127",
                    "r156",
                    "r157",
                    "r315",
                    "r341",
                    "r372",
                    "r373",
                    "r374",
                    "r375",
                    "r498",
                    "r499",
                    "r500",
                    "r501",
                    "r502",
                    "r503",
                    "r504",
                    "r505",
                    "r506",
                    "r507",
                    "r544",
                    "r545"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revision of Prior Period [Axis]"
                            }
                        }
                    },
                "localname":  "RestatementAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RestatementDomain":  {
                "auth_ref":  [
                    "r1",
                    "r99",
                    "r100",
                    "r101",
                    "r102",
                    "r103",
                    "r104",
                    "r105",
                    "r106",
                    "r107",
                    "r109",
                    "r110",
                    "r111",
                    "r112",
                    "r113",
                    "r114",
                    "r127",
                    "r156",
                    "r157",
                    "r315",
                    "r341",
                    "r372",
                    "r373",
                    "r374",
                    "r375",
                    "r498",
                    "r499",
                    "r500",
                    "r501",
                    "r502",
                    "r503",
                    "r504",
                    "r505",
                    "r506",
                    "r507",
                    "r544",
                    "r545"
                    ],
                "localname":  "RestatementDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_TitleOfIndividualAxis":  {
                "auth_ref":  [
                    "r147",
                    "r413"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Axis]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "auth_ref":  [
                    ],
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis":  {
                "auth_ref":  [
                    "r48"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of receivable.",
                            "label":  "Receivable Type [Axis]"
                            }
                        }
                    },
                "localname":  "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r33"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
                            "label":  "Accrued Expenses"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/AccruedExpenses"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r32",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedEmployeeBenefitsCurrent":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Stock-based compensation - common stock"
                            }
                        }
                    },
                "localname":  "AccruedEmployeeBenefitsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedIncomeTaxesCurrent":  {
                "auth_ref":  [
                    "r18",
                    "r473",
                    "r485"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
                            "label":  "Withholding tax"
                            }
                        }
                    },
                "localname":  "AccruedIncomeTaxesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedInsuranceCurrent":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Pension insurance"
                            }
                        }
                    },
                "localname":  "AccruedInsuranceCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        },
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued expenses",
                            "terseLabel":  "Accrued liabilities current",
                            "totalLabel":  "Total accrued expenses",
                            "verboseLabel":  "Accrued Liabilities, Current"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedProfessionalFeesCurrent":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued other professional fees"
                            }
                        }
                    },
                "localname":  "AccruedProfessionalFeesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedSalariesCurrent":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued payroll"
                            }
                        }
                    },
                "localname":  "AccruedSalariesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedVacationCurrent":  {
                "auth_ref":  [
                    "r12",
                    "r36",
                    "r267"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_DeferredCompensationLiabilityCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Vacation"
                            }
                        }
                    },
                "localname":  "AccruedVacationCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Accumulated Other Comprehensive Income (Loss) [Line Items]"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable":  {
                "auth_ref":  [
                    "r58",
                    "r59",
                    "r391",
                    "r392",
                    "r393",
                    "r394",
                    "r395",
                    "r396"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about components of accumulated other comprehensive income (loss).",
                            "label":  "Accumulated Other Comprehensive Income (Loss) [Table]"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r23",
                    "r315",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder.  Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
                            "label":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r99",
                    "r100",
                    "r101",
                    "r312",
                    "r313",
                    "r314",
                    "r373"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Series A and C Convertible Preferred Stock dividends:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings":  {
                "auth_ref":  [
                    "r256",
                    "r263"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.",
                            "label":  "Accrual of earned dividends"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of other increase (decrease) in additional paid in capital (APIC).",
                            "label":  "Issuance of warrants in connection with exchange of convertible notes payable"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalOther",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
                            "label":  "Options"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.",
                            "label":  "Warrants"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued":  {
                "auth_ref":  [
                    "r197",
                    "r256",
                    "r263"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants.  Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
                            "label":  "Issuance of warrants in connection with issuance of convertible notes payable"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to reconcile net loss to net cash used in operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AmortizationOfDebtDiscountPremium":  {
                "auth_ref":  [
                    "r66",
                    "r76",
                    "r221",
                    "r400"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments.  Excludes amortization of financing costs.  Alternate captions include noncash interest expense.",
                            "label":  "Amortization of Debt Discount (Premium)",
                            "negatedLabel":  "Amortization of debt discount",
                            "verboseLabel":  "Amortization of debt discount"
                            }
                        }
                    },
                "localname":  "AmortizationOfDebtDiscountPremium",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfFinancingCostsAndDiscounts":  {
                "auth_ref":  [
                    "r76",
                    "r221",
                    "r231",
                    "r232",
                    "r402"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
                            "label":  "Amortization of debt discount"
                            }
                        }
                    },
                "localname":  "AmortizationOfFinancingCostsAndDiscounts",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r125"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Total"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "auth_ref":  [
                    "r125"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of antidilutive security.",
                            "label":  "Antidilutive Securities [Axis]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "auth_ref":  [
                    "r125"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ArrangementsAndNonarrangementTransactionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
                            }
                        }
                    },
                "localname":  "ArrangementsAndNonarrangementTransactionsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r91",
                    "r140",
                    "r142",
                    "r145",
                    "r154",
                    "r186",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r356",
                    "r361",
                    "r389",
                    "r418",
                    "r420",
                    "r471",
                    "r484"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets [Default Label]",
                            "totalLabel":  "Total Assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r8",
                    "r10",
                    "r50",
                    "r91",
                    "r154",
                    "r186",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r356",
                    "r361",
                    "r389",
                    "r418",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total Current Assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Assets:"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardDateAxis":  {
                "auth_ref":  [
                    "r285",
                    "r311"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by date or year award under share-based payment arrangement is granted.",
                            "label":  "Award Date [Axis]"
                            }
                        }
                    },
                "localname":  "AwardDateAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardDateDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date or year award under share-based payment arrangement is granted."
                            }
                        }
                    },
                "localname":  "AwardDateDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r285",
                    "r311"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_Cash":  {
                "auth_ref":  [
                    "r28",
                    "r420",
                    "r508",
                    "r509"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash [Default Label]",
                            "periodEndLabel":  "Cash"
                            }
                        }
                    },
                "localname":  "Cash",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r6",
                    "r28",
                    "r78"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "auth_ref":  [
                    "r15",
                    "r79"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
                            "label":  "Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":  {
                "auth_ref":  [
                    "r72",
                    "r78",
                    "r84"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
                            "periodEndLabel":  "Cash and Restricted Cash - End of Year",
                            "periodStartLabel":  "Cash and Restricted Cash - Beginning of Year"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r72",
                    "r390"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Net (Decrease) Increase In Cash and Restricted Cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r28"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash equivalents"
                            }
                        }
                    },
                "localname":  "CashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Non-cash investing and financing activities:"
                            }
                        }
                    },
                "localname":  "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    "r88",
                    "r91",
                    "r117",
                    "r118",
                    "r119",
                    "r122",
                    "r124",
                    "r129",
                    "r130",
                    "r131",
                    "r154",
                    "r186",
                    "r190",
                    "r191",
                    "r192",
                    "r195",
                    "r196",
                    "r240",
                    "r241",
                    "r245",
                    "r249",
                    "r389",
                    "r533"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1":  {
                "auth_ref":  [
                    "r257"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise price per share or per unit of warrants or rights outstanding.",
                            "label":  "Warrant exercise price",
                            "periodEndLabel":  "Weighted Average Exercise Price, Outstanding, Ending",
                            "periodStartLabel":  "Weighted Average Exercise Price, Outstanding, Beginning",
                            "terseLabel":  "Warrant exercise price per share",
                            "verboseLabel":  "Exercise price"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of securities into which each warrant or right may be converted.  For example, but not limited to, each warrant may be converted into two shares.",
                            "label":  "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
                            "verboseLabel":  "Warrant to purchase common stock"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights":  {
                "auth_ref":  [
                    "r257"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of securities into which the class of warrant or right may be converted.  For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
                            "label":  "Warrant issued to purchase common stock",
                            "terseLabel":  "Warrant to purchase common stock",
                            "verboseLabel":  "Warrants issued to purchase common stock"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/AdvancesPayableDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r43",
                    "r175",
                    "r477",
                    "r491"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and contingencies (Note 11)"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r172",
                    "r173",
                    "r174",
                    "r182",
                    "r512"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance":  {
                "auth_ref":  [
                    "r45"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate number of common shares reserved for future issuance.",
                            "label":  "Common stock are reserved for issuance under the Plan"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuance",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r99",
                    "r100",
                    "r373"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common stock par or stated value, per share",
                            "verboseLabel":  "Issuance of shares of common stock rate, per share"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common stock, shares authorized"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r22"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common stock, shares issued"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r22",
                    "r256"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r22",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, $0.001 par value, 200,000,000 shares authorized; 34,360,546 and 32,538,411 shares issued and outstanding as of December 31, 2021 and 2020, respectively"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CompensationRelatedCostsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock-based compensation:"
                            }
                        }
                    },
                "localname":  "CompensationRelatedCostsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for comprehensive income.",
                            "label":  "Comprehensive Income (Loss)"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomePolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConsolidationPolicyTextBlock":  {
                "auth_ref":  [
                    "r86",
                    "r358"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
                            "label":  "Principles of Consolidation"
                            }
                        }
                    },
                "localname":  "ConsolidationPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConversionOfStockSharesConverted1":  {
                "auth_ref":  [
                    "r81",
                    "r82",
                    "r83"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares converted in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Number of shares converted",
                            "verboseLabel":  "Conversion of Stock, Shares Converted"
                            }
                        }
                    },
                "localname":  "ConversionOfStockSharesConverted1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ConversionOfStockSharesIssued1":  {
                "auth_ref":  [
                    "r81",
                    "r82",
                    "r83"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Preferred stock shares issued"
                            }
                        }
                    },
                "localname":  "ConversionOfStockSharesIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ConvertibleDebtCurrent":  {
                "auth_ref":  [
                    "r17"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer.  Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
                            "label":  "Convertible notes payable - related parties, net of debt discount of $0 and $75,317 as of December 31, 2021 and 2020, respectively"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleDebtNoncurrent":  {
                "auth_ref":  [
                    "r42"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer.  The debt is convertible into another form of financial instrument, typically the entity's common stock.",
                            "label":  "Convertible notes payable due to related parties"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleDebtTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of convertible debt instrument.  Includes, but is not limited to, principal amount and amortized premium or discount.",
                            "label":  "Schedule of Convertible Notes Payable"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConvertibleNotesPayable":  {
                "auth_ref":  [
                    "r19",
                    "r474",
                    "r486",
                    "r510"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
                            "label":  "Convertible notes payable",
                            "verboseLabel":  "Convertible Notes Payable"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleNotesPayableCurrent":  {
                "auth_ref":  [
                    "r36"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable.  Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
                            "label":  "Convertible Notes Payable, Current"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleNotesPayableMember":  {
                "auth_ref":  [
                    "r17",
                    "r472",
                    "r483",
                    "r510"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
                            "label":  "Convertible Notes Payable [Member]"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConvertiblePreferredStockMember":  {
                "auth_ref":  [
                    "r240",
                    "r241",
                    "r245"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
                            "label":  "Convertible Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "ConvertiblePreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtConversionConvertedInstrumentSharesIssued1":  {
                "auth_ref":  [
                    "r81",
                    "r83"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
                            "label":  "Debt Conversion, Converted Instrument, Shares Issued"
                            }
                        }
                    },
                "localname":  "DebtConversionConvertedInstrumentSharesIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_DebtDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DebtDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtDisclosureTextBlock":  {
                "auth_ref":  [
                    "r87",
                    "r204",
                    "r205",
                    "r206",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r215",
                    "r222",
                    "r223",
                    "r225",
                    "r235"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
                            "label":  "Notes Payable"
                            }
                        }
                    },
                "localname":  "DebtDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayable"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DebtInstrumentAxis":  {
                "auth_ref":  [
                    "r17",
                    "r18",
                    "r19",
                    "r90",
                    "r97",
                    "r198",
                    "r199",
                    "r200",
                    "r201",
                    "r202",
                    "r203",
                    "r205",
                    "r211",
                    "r212",
                    "r213",
                    "r214",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r229",
                    "r230",
                    "r231",
                    "r232",
                    "r403",
                    "r472",
                    "r474",
                    "r483"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
                            "label":  "Debt Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentConvertibleConversionPrice1":  {
                "auth_ref":  [
                    "r200",
                    "r226"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The price per share of the conversion feature embedded in the debt instrument.",
                            "label":  "Debt instrument convertible conversion price",
                            "terseLabel":  "Debt Instrument, Convertible, Conversion Price",
                            "verboseLabel":  "Debt conversion price"
                            }
                        }
                    },
                "localname":  "DebtInstrumentConvertibleConversionPrice1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetailsParenthetical",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature":  {
                "auth_ref":  [
                    "r41",
                    "r257",
                    "r260",
                    "r261"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of conversion terms for debt instrument.",
                            "label":  "Debt conversion, description"
                            }
                        }
                    },
                "localname":  "DebtInstrumentConvertibleTermsOfConversionFeature",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentFaceAmount":  {
                "auth_ref":  [
                    "r198",
                    "r229",
                    "r230",
                    "r401",
                    "r403",
                    "r404"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face (par) amount of debt instrument at time of issuance.",
                            "label":  "Debt instrument, principal amount",
                            "terseLabel":  "Principal amount",
                            "verboseLabel":  "Debt instrument face amount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentFaceAmount",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentInterestRateEffectivePercentage":  {
                "auth_ref":  [
                    "r39",
                    "r227",
                    "r401",
                    "r403"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
                            "label":  "Debt Instrument, Interest Rate, Effective Percentage"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateEffectivePercentage",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentInterestRateStatedPercentage":  {
                "auth_ref":  [
                    "r39",
                    "r199"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contractual interest rate for funds borrowed, under the debt agreement.",
                            "label":  "Debt instrument interest rate",
                            "verboseLabel":  "Interest rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateStatedPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentInterestRateTerms":  {
                "auth_ref":  [
                    "r39"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.",
                            "label":  "Interest rate, description"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateTerms",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Debt Instrument [Line Items]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentMaturityDate":  {
                "auth_ref":  [
                    "r40",
                    "r201",
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
                            "label":  "Debt maturity date",
                            "verboseLabel":  "Debt instrument maturity date"
                            }
                        }
                    },
                "localname":  "DebtInstrumentMaturityDate",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "dateItemType"
                },
            "us-gaap_DebtInstrumentMaturityDateDescription":  {
                "auth_ref":  [
                    "r40"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
                            "label":  "Debt maturity date description"
                            }
                        }
                    },
                "localname":  "DebtInstrumentMaturityDateDescription",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentMaturityDateRangeEnd1":  {
                "auth_ref":  [
                    "r40"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Latest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format.",
                            "label":  "Debt Instrument, Maturity Date Range, End"
                            }
                        }
                    },
                "localname":  "DebtInstrumentMaturityDateRangeEnd1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "dateItemType"
                },
            "us-gaap_DebtInstrumentMaturityDateRangeStart1":  {
                "auth_ref":  [
                    "r40"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Earliest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format.",
                            "label":  "Debt Instrument, Maturity Date Range, Start"
                            }
                        }
                    },
                "localname":  "DebtInstrumentMaturityDateRangeStart1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "dateItemType"
                },
            "us-gaap_DebtInstrumentNameDomain":  {
                "auth_ref":  [
                    "r42",
                    "r90",
                    "r97",
                    "r198",
                    "r199",
                    "r200",
                    "r201",
                    "r202",
                    "r203",
                    "r205",
                    "r211",
                    "r212",
                    "r213",
                    "r214",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r229",
                    "r230",
                    "r231",
                    "r232",
                    "r403"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
                            }
                        }
                    },
                "localname":  "DebtInstrumentNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtInstrumentPeriodicPaymentPrincipal":  {
                "auth_ref":  [
                    "r42"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the required periodic payments applied to principal.",
                            "label":  "Principal amounts",
                            "verboseLabel":  "Principal amount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentPeriodicPaymentPrincipal",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentTable":  {
                "auth_ref":  [
                    "r42",
                    "r90",
                    "r97",
                    "r198",
                    "r199",
                    "r200",
                    "r201",
                    "r202",
                    "r203",
                    "r205",
                    "r211",
                    "r212",
                    "r213",
                    "r214",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r224",
                    "r229",
                    "r230",
                    "r231",
                    "r232",
                    "r257",
                    "r260",
                    "r261",
                    "r262",
                    "r400",
                    "r401",
                    "r403",
                    "r404",
                    "r482"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentUnamortizedDiscount":  {
                "auth_ref":  [
                    "r211",
                    "r400",
                    "r404"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after accumulated amortization, of debt discount.",
                            "label":  "Debt instrument, unamortized discount",
                            "verboseLabel":  "Debt unamortized discount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentUnamortizedDiscount",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentUnamortizedDiscountCurrent":  {
                "auth_ref":  [
                    "r400",
                    "r404"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
                            "label":  "Debt discount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentUnamortizedDiscountCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetailsParenthetical"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
                            }
                        }
                    },
                "localname":  "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredCompensationLiabilityCurrent":  {
                "auth_ref":  [
                    "r268",
                    "r270"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        },
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer).  Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
                            "label":  "Accrued compensation",
                            "totalLabel":  "Total accrued compensation"
                            }
                        }
                    },
                "localname":  "DeferredCompensationLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/ScheduleOfAccruedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFederalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r92",
                    "r338",
                    "r344"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Federal"
                            }
                        }
                    },
                "localname":  "DeferredFederalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFinanceCostsNet":  {
                "auth_ref":  [
                    "r30",
                    "r211",
                    "r402"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after accumulated amortization, of debt issuance costs.  Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
                            "label":  "Debt issuance cost"
                            }
                        }
                    },
                "localname":  "DeferredFinanceCostsNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredForeignIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r92",
                    "r338",
                    "r344"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Foreign"
                            }
                        }
                    },
                "localname":  "DeferredForeignIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r76",
                    "r92",
                    "r338",
                    "r344",
                    "r345",
                    "r346"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Income Tax Expense (Benefit)",
                            "totalLabel":  "Total Deferred"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred tax benefit:"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r92",
                    "r338",
                    "r344"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "US State and local"
                            }
                        }
                    },
                "localname":  "DeferredStateAndLocalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsGross":  {
                "auth_ref":  [
                    "r329"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Gross",
                            "totalLabel":  "Deferred tax assets"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment":  {
                "auth_ref":  [
                    "r336",
                    "r337"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
                            "label":  "Deferred foreign research and development expenses"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsInProcessResearchAndDevelopment",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsNet":  {
                "auth_ref":  [
                    "r331"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Net of Valuation Allowance",
                            "totalLabel":  "Deferred tax assets, net"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r336",
                    "r337"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
                            "label":  "Net operating loss carryforwards"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch":  {
                "auth_ref":  [
                    "r334",
                    "r336",
                    "r337"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
                            "label":  "Deferred Tax Assets, Tax Credit Carryforwards, Research",
                            "verboseLabel":  "Research and development tax credits"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost":  {
                "auth_ref":  [
                    "r336",
                    "r337"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
                            "label":  "Stock-based compensation"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r330"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
                            "label":  "Deferred Tax Assets, Valuation Allowance",
                            "negatedLabel":  "Valuation allowance"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfDeferredTaxAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeContractTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
                            }
                        }
                    },
                "localname":  "DerivativeContractTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date.  Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.",
                            "label":  "Derivative Financial Instruments, Liabilities [Member]"
                            }
                        }
                    },
                "localname":  "DerivativeFinancialInstrumentsLiabilitiesMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DerivativeGainLossOnDerivativeNet":  {
                "auth_ref":  [
                    "r367"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        },
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
                            "label":  "Change in fair value of derivative liabilities",
                            "negatedLabel":  "Change in fair value of derivative liabilities"
                            }
                        }
                    },
                "localname":  "DerivativeGainLossOnDerivativeNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows",
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeInstrumentRiskAxis":  {
                "auth_ref":  [
                    "r53",
                    "r366",
                    "r368",
                    "r369",
                    "r370"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of derivative contract.",
                            "label":  "Derivative Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DerivativeInstrumentRiskAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DerivativeLiabilityMeasurementInput":  {
                "auth_ref":  [
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of input used to measure derivative liability.",
                            "label":  "Derivative liability, measurement input"
                            }
                        }
                    },
                "localname":  "DerivativeLiabilityMeasurementInput",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "decimalItemType"
                },
            "us-gaap_DividendsPayableCurrent":  {
                "auth_ref":  [
                    "r13",
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  14.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued dividend payable",
                            "verboseLabel":  "Additonal preferred dividends payable"
                            }
                        }
                    },
                "localname":  "DividendsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DividendsPreferredStock":  {
                "auth_ref":  [
                    "r263",
                    "r481"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
                            "label":  "Additional accrued dividend payable"
                            }
                        }
                    },
                "localname":  "DividendsPreferredStock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DividendsPreferredStockPaidinkind":  {
                "auth_ref":  [
                    "r263",
                    "r481"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in payment-in-kind (PIK).",
                            "label":  "Payment of dividends in kind"
                            }
                        }
                    },
                "localname":  "DividendsPreferredStockPaidinkind",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EarningsPerShareBasicAndDiluted":  {
                "auth_ref":  [
                    "r123"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Net Loss Per Common Share - Basic and Diluted"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasicAndDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted Average Common Shares Outstanding -"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "auth_ref":  [
                    "r125",
                    "r126"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
                            "label":  "Net Loss Per Common Share"
                            }
                        }
                    },
                "localname":  "EarningsPerSharePolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "auth_ref":  [
                    "r322"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Effective income tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":  {
                "auth_ref":  [
                    "r94",
                    "r322",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
                            "label":  "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
                            "negatedLabel":  "Tax expense at the federal statutory rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r322",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
                            "label":  "Change in valuation allowance"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationDeductions":  {
                "auth_ref":  [
                    "r322",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction.  Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.",
                            "label":  "Permanent differences"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationDeductions",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential":  {
                "auth_ref":  [
                    "r322",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
                            "label":  "Statutory rate differential - domestic versus foreign"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes":  {
                "auth_ref":  [
                    "r322",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
                            "label":  "Prior period true-up and other"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes":  {
                "auth_ref":  [
                    "r322",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
                            "label":  "State and local taxes, net of federal benefit"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch":  {
                "auth_ref":  [
                    "r322",
                    "r348"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
                            "label":  "Research and development tax credits"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EmployeeRelatedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued director compensation"
                            }
                        }
                    },
                "localname":  "EmployeeRelatedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized":  {
                "auth_ref":  [
                    "r310"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
                            "label":  "Unrecognized stock based compensation expense"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1":  {
                "auth_ref":  [
                    "r310"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Unrecognized stock based compensation expense, years"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r0",
                    "r58",
                    "r59",
                    "r60",
                    "r99",
                    "r100",
                    "r101",
                    "r103",
                    "r110",
                    "r113",
                    "r128",
                    "r155",
                    "r256",
                    "r263",
                    "r312",
                    "r313",
                    "r314",
                    "r340",
                    "r341",
                    "r373",
                    "r391",
                    "r392",
                    "r393",
                    "r394",
                    "r395",
                    "r396",
                    "r498",
                    "r499",
                    "r500",
                    "r545"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyTables",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueAdjustmentOfWarrants":  {
                "auth_ref":  [
                    "r76",
                    "r236"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense (income) related to adjustment to fair value of warrant liability.",
                            "label":  "Fair value of warrants",
                            "terseLabel":  "Fair value of warrant",
                            "verboseLabel":  "Warrants fair value"
                            }
                        }
                    },
                "localname":  "FairValueAdjustmentOfWarrants",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/AdvancesPayableDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable":  {
                "auth_ref":  [
                    "r376",
                    "r377",
                    "r378",
                    "r385"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
                            "label":  "Fair Value, Recurring and Nonrecurring [Table]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable":  {
                "auth_ref":  [
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
                            "label":  "Fair Value Measurement Inputs and Valuation Techniques [Table]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock":  {
                "auth_ref":  [
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
                            "label":  "Schedule of Assumptions Used for Valuation of Level 3 Liabilities"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/FairValueTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss":  {
                "auth_ref":  [
                    "r383"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.",
                            "label":  "Change in fair value"
                            }
                        }
                    },
                "localname":  "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock":  {
                "auth_ref":  [
                    "r382",
                    "r385"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
                            "label":  "Schedule of Changes in Fair Value of Liabilities Measured at Fair Value on a Recurring Basis"
                            }
                        }
                    },
                "localname":  "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/FairValueTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueByFairValueHierarchyLevelAxis":  {
                "auth_ref":  [
                    "r213",
                    "r229",
                    "r230",
                    "r272",
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r277",
                    "r278",
                    "r280",
                    "r377",
                    "r427",
                    "r428",
                    "r429"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
                            "label":  "Fair Value Hierarchy and NAV [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByFairValueHierarchyLevelAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByLiabilityClassAxis":  {
                "auth_ref":  [
                    "r384",
                    "r385"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by class of liability.",
                            "label":  "Liability Class [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByLiabilityClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByMeasurementFrequencyAxis":  {
                "auth_ref":  [
                    "r376",
                    "r377",
                    "r380",
                    "r381",
                    "r386"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by measurement frequency.",
                            "label":  "Measurement Frequency [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByMeasurementFrequencyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value Disclosures [Abstract]"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r384"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities.  Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
                            "label":  "Fair Value"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/FairValue"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueInputsLevel3Member":  {
                "auth_ref":  [
                    "r213",
                    "r229",
                    "r230",
                    "r272",
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r277",
                    "r278",
                    "r280",
                    "r377",
                    "r429"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value, Inputs, Level 3 [Member]"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel3Member",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain":  {
                "auth_ref":  [
                    "r382"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents classes of liabilities measured and disclosed at fair value."
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementFrequencyDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement frequency."
                            }
                        }
                    },
                "localname":  "FairValueMeasurementFrequencyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementsFairValueHierarchyDomain":  {
                "auth_ref":  [
                    "r213",
                    "r229",
                    "r230",
                    "r272",
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r277",
                    "r278",
                    "r280",
                    "r427",
                    "r428",
                    "r429"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Categories used to prioritize the inputs to valuation techniques to measure fair value."
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsFairValueHierarchyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementsRecurringMember":  {
                "auth_ref":  [
                    "r384",
                    "r386"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Frequent fair value measurement.  Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
                            "label":  "Fair Value, Recurring [Member]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsRecurringMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueOfFinancialInstrumentsPolicy":  {
                "auth_ref":  [
                    "r387",
                    "r388"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for determining the fair value of financial instruments.",
                            "label":  "Fair Value of Financial Instruments"
                            }
                        }
                    },
                "localname":  "FairValueOfFinancialInstrumentsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FinanceLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r405"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  13.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
                            "label":  "Financing liability"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeasePrincipalPayments":  {
                "auth_ref":  [
                    "r406",
                    "r407"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for principal payment on finance lease.",
                            "label":  "Finance Lease, Principal Payments",
                            "negatedLabel":  "Repayment of financing liability"
                            }
                        }
                    },
                "localname":  "FinanceLeasePrincipalPayments",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinancialInstrumentAxis":  {
                "auth_ref":  [
                    "r149",
                    "r150",
                    "r151",
                    "r152",
                    "r153",
                    "r158",
                    "r159",
                    "r160",
                    "r161",
                    "r162",
                    "r163",
                    "r164",
                    "r165",
                    "r166",
                    "r224",
                    "r254",
                    "r371",
                    "r424",
                    "r425",
                    "r426",
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r436",
                    "r437",
                    "r438",
                    "r439",
                    "r440",
                    "r441",
                    "r442",
                    "r443",
                    "r444",
                    "r445",
                    "r446",
                    "r447",
                    "r448",
                    "r449",
                    "r450",
                    "r451",
                    "r452",
                    "r453",
                    "r533",
                    "r534",
                    "r535",
                    "r536",
                    "r537",
                    "r538",
                    "r539"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of financial instrument.",
                            "label":  "Financial Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "FinancialInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ForeignCountryMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
                            "label":  "Foreign Tax Authority [Member]"
                            }
                        }
                    },
                "localname":  "ForeignCountryMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ForeignCurrencyExchangeRateTranslation1":  {
                "auth_ref":  [
                    "r397",
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.",
                            "label":  "Foreign currency exchange rate translation"
                            }
                        }
                    },
                "localname":  "ForeignCurrencyExchangeRateTranslation1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "pureItemType"
                },
            "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock":  {
                "auth_ref":  [
                    "r399"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
                            "label":  "Foreign Currency Translation"
                            }
                        }
                    },
                "localname":  "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_GainsLossesOnExtinguishmentOfDebt":  {
                "auth_ref":  [
                    "r76",
                    "r233",
                    "r234"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        },
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
                            "label":  "Loss on extinguishment of notes payable",
                            "negatedLabel":  "Loss on extinguishment of notes payable",
                            "verboseLabel":  "Gain loss on extinguishment of debt"
                            }
                        }
                    },
                "localname":  "GainsLossesOnExtinguishmentOfDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfCashFlows",
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r64"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "General and administrative"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpenseMember":  {
                "auth_ref":  [
                    "r63"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing general and administrative expense.",
                            "label":  "General and Administrative Expense [Member]"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic":  {
                "auth_ref":  [
                    "r93",
                    "r347"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
                            "label":  "United States"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":  {
                "auth_ref":  [
                    "r61",
                    "r140",
                    "r141",
                    "r143",
                    "r144",
                    "r146",
                    "r469",
                    "r478",
                    "r480",
                    "r494"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Loss before income taxes"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign":  {
                "auth_ref":  [
                    "r93",
                    "r347"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
                            "label":  "Israel"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfIncomeBeforeIncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "auth_ref":  [
                    "r170",
                    "r171"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by location in the income statement.",
                            "label":  "Income Statement Location [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "auth_ref":  [
                    "r171"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Location in the income statement."
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxAuthorityAxis":  {
                "auth_ref":  [
                    "r325"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by tax jurisdiction.",
                            "label":  "Income Tax Authority [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeTaxAuthorityAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxAuthorityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
                            }
                        }
                    },
                "localname":  "IncomeTaxAuthorityDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r94",
                    "r323",
                    "r327",
                    "r333",
                    "r342",
                    "r349",
                    "r351",
                    "r352",
                    "r353"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense":  {
                "auth_ref":  [
                    "r324"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
                            "label":  "Income tax interest and penalties"
                            }
                        }
                    },
                "localname":  "IncomeTaxExaminationPenaltiesAndInterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r95",
                    "r112",
                    "r113",
                    "r139",
                    "r321",
                    "r343",
                    "r350",
                    "r495"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense (Benefit)",
                            "totalLabel":  "Provision for income taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfComponentOfIncomeTaxExpensesBenefitDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r57",
                    "r319",
                    "r320",
                    "r327",
                    "r328",
                    "r332",
                    "r339"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income Tax, Policy [Policy Text Block]",
                            "verboseLabel":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r322"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
                            "verboseLabel":  "Change in valuation allowance"
                            }
                        }
                    },
                "localname":  "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxesPaidNet":  {
                "auth_ref":  [
                    "r80"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
                            "label":  "Income taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayable":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  14.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
                            "label":  "Increase (Decrease) in Accounts Payable",
                            "verboseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  15.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
                            "label":  "Increase (Decrease) in Accrued Liabilities",
                            "verboseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInDeferredCompensation":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  19.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
                            "label":  "Increase (Decrease) in Deferred Compensation",
                            "verboseLabel":  "Accrued compensation"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInDeferredCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInInterestPayableNet":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  17.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
                            "label":  "Increase (Decrease) in Interest Payable, Net",
                            "verboseLabel":  "Accrued interest"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInInterestPayableNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Changes in operating assets and liabilities:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherCurrentAssets":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  13.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in current assets classified as other.",
                            "label":  "Increase (Decrease) in Other Current Assets",
                            "negatedLabel":  "Other current assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherCurrentAssets",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidExpense":  {
                "auth_ref":  [
                    "r75"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
                            "label":  "Increase (Decrease) in Prepaid Expense",
                            "negatedLabel":  "Prepaid expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseDebt":  {
                "auth_ref":  [
                    "r66",
                    "r219",
                    "r228",
                    "r231",
                    "r232"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
                            "label":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpenseDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseOther":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest expense classified as other.",
                            "label":  "Interest Expense, Other",
                            "negatedLabel":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpenseOther",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPaidNet":  {
                "auth_ref":  [
                    "r70",
                    "r73",
                    "r80"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity.  Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
                            "label":  "Interest"
                            }
                        }
                    },
                "localname":  "InterestPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPayableCurrent":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued interest"
                            }
                        }
                    },
                "localname":  "InterestPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPayableCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r476",
                    "r492"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest payable on debt, including, but not limited to, trade payables.",
                            "label":  "Interest Payable",
                            "verboseLabel":  "Accrued interest"
                            }
                        }
                    },
                "localname":  "InterestPayableCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r27",
                    "r91",
                    "r154",
                    "r389",
                    "r420",
                    "r475",
                    "r490"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total Liabilities and Stockholders\u2019 Deficiency"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Stockholders\u2019 Deficiency"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r38",
                    "r91",
                    "r154",
                    "r186",
                    "r187",
                    "r188",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r357",
                    "r361",
                    "r362",
                    "r389",
                    "r418",
                    "r419",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilityForUncertainTaxPositionsCurrent":  {
                "auth_ref":  [
                    "r36"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount recognized for uncertainty in income taxes classified as current.",
                            "label":  "Uncertain tax positions"
                            }
                        }
                    },
                "localname":  "LiabilityForUncertainTaxPositionsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LitigationSettlementAmountAwardedFromOtherParty":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount awarded from other party in judgment or settlement of litigation.",
                            "label":  "Litigation settlement, amount awarded from other party"
                            }
                        }
                    },
                "localname":  "LitigationSettlementAmountAwardedFromOtherParty",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongtermDebtTypeAxis":  {
                "auth_ref":  [
                    "r42"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-term debt.",
                            "label":  "Long-term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongtermDebtTypeDomain":  {
                "auth_ref":  [
                    "r42",
                    "r185"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetails",
                    "http://cellsource.com/role/ScheduleOfConvertibleNotesPayableDueToRelatedPartiesDetailsParenthetical",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LossContingenciesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Loss Contingencies [Line Items]"
                            }
                        }
                    },
                "localname":  "LossContingenciesLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LossContingenciesTable":  {
                "auth_ref":  [
                    "r175",
                    "r176",
                    "r177",
                    "r178",
                    "r179",
                    "r180",
                    "r181",
                    "r183",
                    "r184"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made.  Excludes environmental contingencies, warranties and unconditional purchase obligations.",
                            "label":  "Loss Contingencies [Table]"
                            }
                        }
                    },
                "localname":  "LossContingenciesTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_MeasurementInputExpectedDividendRateMember":  {
                "auth_ref":  [
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using expected dividend rate to be paid to holder of share per year.",
                            "label":  "Measurement Input, Expected Dividend Rate [Member]"
                            }
                        }
                    },
                "localname":  "MeasurementInputExpectedDividendRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputExpectedTermMember":  {
                "auth_ref":  [
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using period financial instrument is expected to be outstanding.  Excludes maturity date.",
                            "label":  "Measurement Input, Expected Term [Member]"
                            }
                        }
                    },
                "localname":  "MeasurementInputExpectedTermMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputPriceVolatilityMember":  {
                "auth_ref":  [
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
                            "label":  "Measurement Input, Price Volatility [Member]"
                            }
                        }
                    },
                "localname":  "MeasurementInputPriceVolatilityMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputRiskFreeInterestRateMember":  {
                "auth_ref":  [
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using interest rate on instrument with zero risk of financial loss.",
                            "label":  "Measurement Input, Risk Free Interest Rate [Member]"
                            }
                        }
                    },
                "localname":  "MeasurementInputRiskFreeInterestRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputTypeAxis":  {
                "auth_ref":  [
                    "r379"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of measurement input used to determine value of asset and liability.",
                            "label":  "Measurement Input Type [Axis]"
                            }
                        }
                    },
                "localname":  "MeasurementInputTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_MeasurementInputTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input used to determine value of asset and liability."
                            }
                        }
                    },
                "localname":  "MeasurementInputTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAssumptionsUsedForValuationOfLevel3LiabilitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r72"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net Cash Provided By Financing Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash Flows From Financing Activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r72",
                    "r74",
                    "r77"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "negatedLabel":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net Cash Used In Operating Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash Flows From Operating Activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r3",
                    "r55",
                    "r56",
                    "r60",
                    "r62",
                    "r77",
                    "r91",
                    "r102",
                    "r104",
                    "r105",
                    "r107",
                    "r108",
                    "r112",
                    "r113",
                    "r120",
                    "r140",
                    "r141",
                    "r143",
                    "r144",
                    "r146",
                    "r154",
                    "r186",
                    "r187",
                    "r188",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r375",
                    "r389",
                    "r479",
                    "r493"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "negatedLabel":  "Net Income (Loss) Attributable to Parent",
                            "totalLabel":  "Net Loss",
                            "verboseLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfCashFlows",
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic":  {
                "auth_ref":  [
                    "r104",
                    "r105",
                    "r107",
                    "r108",
                    "r115",
                    "r116",
                    "r121",
                    "r124",
                    "r140",
                    "r141",
                    "r143",
                    "r144",
                    "r146"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
                            "label":  "Net Income (Loss) Available to Common Stockholders, Basic",
                            "totalLabel":  "Net Loss Applicable to Common Stockholders"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAvailableToCommonStockholdersBasic",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "Recent Accounting Standards"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r65"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
                            "label":  "Nonoperating Income (Expense)",
                            "totalLabel":  "Total Other Expense"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NotesPayable":  {
                "auth_ref":  [
                    "r19",
                    "r474",
                    "r487"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
                            "label":  "Notes Payable [Default Label]",
                            "verboseLabel":  "Notes payable"
                            }
                        }
                    },
                "localname":  "NotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NotesPayableCurrent":  {
                "auth_ref":  [
                    "r35"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
                            "label":  "Notes payable",
                            "verboseLabel":  "Total"
                            }
                        }
                    },
                "localname":  "NotesPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent":  {
                "auth_ref":  [
                    "r31",
                    "r96",
                    "r412"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount for notes payable (written promise to pay), due to related parties.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Notes payable - related parties",
                            "verboseLabel":  "Notes payable due to related parties"
                            }
                        }
                    },
                "localname":  "NotesPayableRelatedPartiesClassifiedCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/ScheduleOfNotesPayableDueToRelatedPartiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OffsettingAssetsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Offsetting Assets [Line Items]"
                            }
                        }
                    },
                "localname":  "OffsettingAssetsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OffsettingAssetsTable":  {
                "auth_ref":  [
                    "r51",
                    "r52"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
                            "label":  "Offsetting Assets [Table]"
                            }
                        }
                    },
                "localname":  "OffsettingAssetsTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services.  Includes selling, general and administrative expense.",
                            "label":  "Operating Expenses",
                            "totalLabel":  "Total Operating Expenses"
                            }
                        }
                    },
                "localname":  "OperatingExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Expenses:"
                            }
                        }
                    },
                "localname":  "OperatingExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r140",
                    "r141",
                    "r143",
                    "r144",
                    "r146"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Loss From Operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r334"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
                            "label":  "Operating loss carryforwards"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLossCarryforwardsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Operating Loss Carryforwards [Line Items]"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwardsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingLossCarryforwardsTable":  {
                "auth_ref":  [
                    "r335"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
                            "label":  "Operating Loss Carryforwards [Table]"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwardsTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r5",
                    "r365"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
                            "label":  "Business Organization, Nature of Operations and Risks and Uncertainties"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BusinessOrganizationNatureOfOperationsAndRisksAndUncertainties"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_OtherAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r14",
                    "r36"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other accrued expenses"
                            }
                        }
                    },
                "localname":  "OtherAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsCurrent":  {
                "auth_ref":  [
                    "r49",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current assets classified as other.",
                            "label":  "Other current assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax":  {
                "auth_ref":  [
                    "r54"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
                            "label":  "Restructuring reserve translation adjustment"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherLiabilitiesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Liabilities Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherLiabilitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r37"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for other liabilities.",
                            "label":  "Advances Payable"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/AdvancesPayable"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_OtherNoncashExpense":  {
                "auth_ref":  [
                    "r77"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
                            "label":  "Non-cash interest expense - warrants"
                            }
                        }
                    },
                "localname":  "OtherNoncashExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other (Expense) Income:"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PayablesAndAccrualsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payables and Accruals [Abstract]"
                            }
                        }
                    },
                "localname":  "PayablesAndAccrualsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PlanNameAxis":  {
                "auth_ref":  [
                    "r285",
                    "r311"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Axis]"
                            }
                        }
                    },
                "localname":  "PlanNameAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PlanNameDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Plan name for share-based payment arrangement."
                            }
                        }
                    },
                "localname":  "PlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockDividendPaymentTerms":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r257"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Specific information regarding dividend payment dates or timing and whether or not dividends are paid on a cumulative basis.",
                            "label":  "Preferred Stock, Dividend Payment Terms"
                            }
                        }
                    },
                "localname":  "PreferredStockDividendPaymentTerms",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PreferredStockDividendRatePercentage":  {
                "auth_ref":  [
                    "r241"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The percentage rate used to calculate dividend payments on preferred stock.",
                            "label":  "Preferred stock devidend, percentage"
                            }
                        }
                    },
                "localname":  "PreferredStockDividendRatePercentage",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_PreferredStockDividendsIncomeStatementImpact":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
                            "label":  "Preferred Stock Dividends, Income Statement Impact",
                            "negatedLabel":  "Dividend attributable to Series A and Series C preferred stockholders"
                            }
                        }
                    },
                "localname":  "PreferredStockDividendsIncomeStatementImpact",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PreferredStockLiquidationPreferenceValue":  {
                "auth_ref":  [
                    "r88",
                    "r245"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
                            "label":  "Preferred stock liquidation preference value"
                            }
                        }
                    },
                "localname":  "PreferredStockLiquidationPreferenceValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation.  Preferred shares typically represent an ownership interest in the company.",
                            "label":  "Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "PreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r21",
                    "r240"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred stock par or stated value, per share",
                            "verboseLabel":  "Preferred stock, par value"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred stock, shares authorized",
                            "verboseLabel":  "Preferred stock, authorized shares"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r21",
                    "r240"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred stock, shares issued"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r21",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred stock, value"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PreferredStockVotingRights":  {
                "auth_ref":  [
                    "r21",
                    "r257"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of voting rights of nonredeemable preferred stock.  Includes eligibility to vote and votes per share owned.  Include also, if any, unusual voting rights.",
                            "label":  "Preferred stock voting rights, description"
                            }
                        }
                    },
                "localname":  "PreferredStockVotingRights",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PrepaidExpenseCurrent":  {
                "auth_ref":  [
                    "r7",
                    "r9",
                    "r167",
                    "r168"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid expenses"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PriorPeriodReclassificationAdjustmentDescription":  {
                "auth_ref":  [
                    "r2"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for reclassification affecting comparability of financial statement.  Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
                            "label":  "Reclassifications"
                            }
                        }
                    },
                "localname":  "PriorPeriodReclassificationAdjustmentDescription",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ProceedsFromConvertibleDebt":  {
                "auth_ref":  [
                    "r68"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
                            "label":  "Proceeds from issuance of convertible notes payable",
                            "terseLabel":  "Proceeds from convertible debt",
                            "verboseLabel":  "Proceeds from issuance of convertible debt"
                            }
                        }
                    },
                "localname":  "ProceedsFromConvertibleDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r67"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Convertible preferred stock, value"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
                            "label":  "Proceeds from issuance of Series A Preferred Stock"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfConvertiblePreferredStock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromNotesPayable":  {
                "auth_ref":  [
                    "r68"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
                            "label":  "Proceeds from issuance of notes payable"
                            }
                        }
                    },
                "localname":  "ProceedsFromNotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromOtherDebt":  {
                "auth_ref":  [
                    "r68"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from debt classified as other.",
                            "label":  "Proceeds from advances payable"
                            }
                        }
                    },
                "localname":  "ProceedsFromOtherDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromRelatedPartyDebt":  {
                "auth_ref":  [
                    "r68"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.  Alternate caption:  Proceeds from Advances from Affiliates.",
                            "label":  "Proceeds from issuance of convertible notes payable - related party"
                            }
                        }
                    },
                "localname":  "ProceedsFromRelatedPartyDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromWarrantExercises":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from holders exercising their stock warrants.",
                            "label":  "Proceeds from warrant exercise",
                            "verboseLabel":  "Proceeds from warrant exercised"
                            }
                        }
                    },
                "localname":  "ProceedsFromWarrantExercises",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProfitLoss":  {
                "auth_ref":  [
                    "r3",
                    "r55",
                    "r56",
                    "r60",
                    "r71",
                    "r91",
                    "r102",
                    "r112",
                    "r113",
                    "r140",
                    "r141",
                    "r143",
                    "r144",
                    "r146",
                    "r154",
                    "r186",
                    "r187",
                    "r188",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r194",
                    "r195",
                    "r196",
                    "r355",
                    "r359",
                    "r360",
                    "r363",
                    "r364",
                    "r375",
                    "r389",
                    "r480"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
                            "label":  "Net loss"
                            }
                        }
                    },
                "localname":  "ProfitLoss",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Property, Plant and Equipment [Line Items]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ReceivableTypeDomain":  {
                "auth_ref":  [
                    "r48"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
                            }
                        }
                    },
                "localname":  "ReceivableTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfChangesInFairValueOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyDomain":  {
                "auth_ref":  [
                    "r279",
                    "r410",
                    "r411"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
                            }
                        }
                    },
                "localname":  "RelatedPartyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionAxis":  {
                "auth_ref":  [
                    "r279",
                    "r410",
                    "r411",
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party transaction.",
                            "label":  "Related Party Transaction [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionDomain":  {
                "auth_ref":  [
                    "r279"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Transaction between related party."
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "auth_ref":  [
                    "r279",
                    "r410",
                    "r414",
                    "r457",
                    "r458",
                    "r459",
                    "r460",
                    "r461",
                    "r462",
                    "r463",
                    "r464",
                    "r465",
                    "r466",
                    "r467",
                    "r468"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r408",
                    "r409",
                    "r411",
                    "r415",
                    "r416"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/RelatedPartyTransactions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentsOfConvertibleDebt":  {
                "auth_ref":  [
                    "r69"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
                            "label":  "Repayments of convertible debt",
                            "negatedLabel":  "Repayment of convertible notes payable"
                            }
                        }
                    },
                "localname":  "RepaymentsOfConvertibleDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfNotesPayable":  {
                "auth_ref":  [
                    "r69"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
                            "label":  "Repayments of notes payable",
                            "negatedLabel":  "Repayment of notes payable"
                            }
                        }
                    },
                "localname":  "RepaymentsOfNotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfOtherDebt":  {
                "auth_ref":  [
                    "r69"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for the payment of debt classified as other.",
                            "label":  "Repayments of Other Debt",
                            "negatedLabel":  "Repayment of advances payable"
                            }
                        }
                    },
                "localname":  "RepaymentsOfOtherDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfRelatedPartyDebt":  {
                "auth_ref":  [
                    "r69"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.  Alternate caption:  Payments for Advances from Affiliates.",
                            "label":  "Repayments of related party debt"
                            }
                        }
                    },
                "localname":  "RepaymentsOfRelatedPartyDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "auth_ref":  [
                    "r317",
                    "r455",
                    "r516"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
                            "label":  "Research and development",
                            "verboseLabel":  "Research and development expense"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpenseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption in which the reported facts about research and development expense have been included.",
                            "label":  "Research and Development Expense [Member]"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpensePolicy":  {
                "auth_ref":  [
                    "r317"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
                            "label":  "Research and Development"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpensePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RestrictedCash":  {
                "auth_ref":  [
                    "r84",
                    "r470",
                    "r488"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash restricted as to withdrawal or usage.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
                            "label":  "Restricted Cash",
                            "periodEndLabel":  "Restricted cash"
                            }
                        }
                    },
                "localname":  "RestrictedCash",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalents":  {
                "auth_ref":  [
                    "r15",
                    "r78",
                    "r84",
                    "r470",
                    "r488"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents restricted as to withdrawal or usage.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Restricted Cash and Cash Equivalents",
                            "periodEndLabel":  "Cash and restricted cash"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash and restricted cash consisted of the following:"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestrictedCashNoncurrent":  {
                "auth_ref":  [
                    "r11",
                    "r16",
                    "r84",
                    "r511"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash restricted as to withdrawal or usage, classified as noncurrent.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
                            "label":  "Restricted cash"
                            }
                        }
                    },
                "localname":  "RestrictedCashNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r24",
                    "r263",
                    "r315",
                    "r420",
                    "r489",
                    "r502",
                    "r507"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Accumulated deficit",
                            "negatedLabel":  "Retained Earnings (Accumulated Deficit)"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r0",
                    "r99",
                    "r100",
                    "r101",
                    "r103",
                    "r110",
                    "r113",
                    "r155",
                    "r312",
                    "r313",
                    "r314",
                    "r340",
                    "r341",
                    "r373",
                    "r498",
                    "r500"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockConsiderationReceivedOnTransaction":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash received on stock transaction after deduction of issuance costs.",
                            "label":  "Sale of stock transaction amount"
                            }
                        }
                    },
                "localname":  "SaleOfStockConsiderationReceivedOnTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
                            "label":  "Sale of conversion shares"
                            }
                        }
                    },
                "localname":  "SaleOfStockNumberOfSharesIssuedInTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SaleOfStockPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
                            "label":  "Sale of stock price per share"
                            }
                        }
                    },
                "localname":  "SaleOfStockPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).  An alternative caption includes accrued expenses.",
                            "label":  "Schedule of Accrued Expenses"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/AccruedExpensesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable":  {
                "auth_ref":  [
                    "r125"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r125"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
                            "label":  "Schedule of Weighted Average Dilutive Common Shares Anti-dilutive"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock":  {
                "auth_ref":  [
                    "r339"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
                            "label":  "Schedule of Component of Income Tax Expenses (Benefit)"
                            }
                        }
                    },
                "localname":  "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable":  {
                "auth_ref":  [
                    "r266",
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees.  The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements.  This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee.  Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
                            "label":  "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    "r331"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
                            "label":  "Schedule of Deferred Tax Assets"
                            }
                        }
                    },
                "localname":  "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock":  {
                "auth_ref":  [
                    "r322"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
                            "label":  "Schedule of Effective Income Tax Rate Reconciliation"
                            }
                        }
                    },
                "localname":  "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock":  {
                "auth_ref":  [
                    "r92"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
                            "label":  "Schedule of Income Before Income Taxes"
                            }
                        }
                    },
                "localname":  "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable":  {
                "auth_ref":  [
                    "r29",
                    "r169"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfPropertyPlantAndEquipmentTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock":  {
                "auth_ref":  [
                    "r311"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
                            "label":  "Schedule of Outstanding and Exercisable"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r289",
                    "r298",
                    "r300"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
                            "label":  "Summary of Stock Option Activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock":  {
                "auth_ref":  [
                    "r304"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
                            "label":  "Schedule of Stock Options Assumption Used"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShortTermDebtTable":  {
                "auth_ref":  [
                    "r34"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance.  It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
                            "label":  "Schedule of Short-term Debt [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShortTermDebtTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShortTermDebtTextBlock":  {
                "auth_ref":  [
                    "r34"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
                            "label":  "Schedule of Notes Payable"
                            }
                        }
                    },
                "localname":  "ScheduleOfShortTermDebtTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r44",
                    "r88",
                    "r129",
                    "r130",
                    "r237",
                    "r238",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243",
                    "r245",
                    "r249",
                    "r254",
                    "r257",
                    "r258",
                    "r259",
                    "r260",
                    "r261",
                    "r262",
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock":  {
                "auth_ref":  [
                    "r264",
                    "r283"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of warrants or rights issued.  Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame.  Warrants are often included in a new debt issue to entice investors by a higher return potential.  The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company.  Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.  Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
                            "label":  "Schedule of Warrant Activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SeriesCPreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Series C Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "SeriesCPreferredStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r75"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Stock-based compensation:"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1":  {
                "auth_ref":  [
                    "r286"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.  Includes, but is not limited to, combination of market, performance or service condition.",
                            "label":  "Warrants vesting period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/AdvancesPayableDetailsNarrative"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":  {
                "auth_ref":  [
                    "r307"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
                            "label":  "Expected dividends"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":  {
                "auth_ref":  [
                    "r306"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Expected volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":  {
                "auth_ref":  [
                    "r308"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Risk-free interest rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised":  {
                "auth_ref":  [
                    "r295"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of non-option equity instruments exercised by participants.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised",
                            "negatedLabel":  "Number of Warrants, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations":  {
                "auth_ref":  [
                    "r296"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares under non-option equity instrument agreements that were either cancelled or expired.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations",
                            "negatedLabel":  "Number of Warrants, Expired/Cacelled"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted":  {
                "auth_ref":  [
                    "r294"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net number of non-option equity instruments granted to participants.",
                            "label":  "Number of Warrants, Issued"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber":  {
                "auth_ref":  [
                    "r290",
                    "r292"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
                            "periodEndLabel":  "Number of Warrants, Outstanding, Ending",
                            "periodStartLabel":  "Number of Warrants, Outstanding, Beginning"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "auth_ref":  [
                    "r293"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
                            "periodEndLabel":  "Number of Options, Exercisable, Ending"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r293"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
                            "periodEndLabel":  "Weighted Average Exercise Price, Exercisable, Beginning"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod":  {
                "auth_ref":  [
                    "r296"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
                            "negatedLabel":  "Number of Options, Expired/forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r296"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price of options that were either forfeited or expired.",
                            "label":  "Weighted Average Exercise Price, Expired/forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Number of Options, Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r299"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
                            "label":  "Weighted average estimated grant date fair value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":  {
                "auth_ref":  [
                    "r311"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
                            "periodEndLabel":  "Intrinsic Value, Outstanding, Ending"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r291",
                    "r311"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
                            "periodEndLabel":  "Number of Options, Outstanding, Ending",
                            "periodStartLabel":  "Number of Options, Outstanding, Beginning"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r290"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "periodEndLabel":  "Weighted Average Exercise Price, Outstanding, Ending",
                            "periodStartLabel":  "Weighted Average Exercise Price, Outstanding, Beginning"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r283",
                    "r287"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement."
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
                            "label":  "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
                            "verboseLabel":  "Weighted Average Exercise Price, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
                            "label":  "Weighted Average Exercise Price, Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "auth_ref":  [
                    "r285",
                    "r288"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost.",
                            "label":  "Stock-Based Compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":  {
                "auth_ref":  [
                    "r303"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by range of option prices pertaining to options granted.",
                            "label":  "Exercise Price Range [Axis]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain":  {
                "auth_ref":  [
                    "r309"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions":  {
                "auth_ref":  [
                    "r297"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
                            "label":  "Exercisable, Outstanding Number Of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions":  {
                "auth_ref":  [
                    "r291"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
                            "label":  "Outstanding, Outstanding Number Of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SharePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Price of a single share of a number of saleable stocks of a company.",
                            "label":  "Share price"
                            }
                        }
                    },
                "localname":  "SharePrice",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/AdvancesPayableDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Intrinsic value of outstanding award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
                            "periodEndLabel":  "Intrinsic Value, Outstanding, Ending"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfWarrantActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1":  {
                "auth_ref":  [
                    "r305",
                    "r316"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Expected term (years)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":  {
                "auth_ref":  [
                    "r311"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
                            "periodEndLabel":  "Intrinsic Value, Exercisable, Ending"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    "r311"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
                            "verboseLabel":  "Weighted Average Remaining Life (In Years), Exercisable"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r301"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
                            "verboseLabel":  "Weighted Average Remaining Life (In Years), Outstanding"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average grant-date fair value of options vested.",
                            "label":  "Common stock fair value per share"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r302"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Exercisable, Weighted Average Remaining Life (In Years)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1":  {
                "auth_ref":  [
                    "r291"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
                            "label":  "Outstanding, Exercise Price"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharesIssuedPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share or per unit amount of equity securities issued.",
                            "label":  "Exercise price",
                            "verboseLabel":  "Shares Issued, Price Per Share"
                            }
                        }
                    },
                "localname":  "SharesIssuedPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Ending balance, shares",
                            "periodStartLabel":  "Beginning balance, shares"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShortTermDebtLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Short-term Debt [Line Items]"
                            }
                        }
                    },
                "localname":  "ShortTermDebtLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShortTermDebtTypeAxis":  {
                "auth_ref":  [
                    "r34"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of short-term debt arrangement.",
                            "label":  "Short-term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "ShortTermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShortTermDebtTypeDomain":  {
                "auth_ref":  [
                    "r32"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
                            }
                        }
                    },
                "localname":  "ShortTermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r85",
                    "r98"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Summary of Significant Accounting Policies"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r22",
                    "r88",
                    "r91",
                    "r117",
                    "r118",
                    "r119",
                    "r122",
                    "r124",
                    "r129",
                    "r130",
                    "r131",
                    "r154",
                    "r186",
                    "r190",
                    "r191",
                    "r192",
                    "r195",
                    "r196",
                    "r240",
                    "r241",
                    "r245",
                    "r249",
                    "r256",
                    "r389",
                    "r533"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r0",
                    "r47",
                    "r58",
                    "r59",
                    "r60",
                    "r99",
                    "r100",
                    "r101",
                    "r103",
                    "r110",
                    "r113",
                    "r128",
                    "r155",
                    "r256",
                    "r263",
                    "r312",
                    "r313",
                    "r314",
                    "r340",
                    "r341",
                    "r373",
                    "r391",
                    "r392",
                    "r393",
                    "r394",
                    "r395",
                    "r396",
                    "r498",
                    "r499",
                    "r500",
                    "r545"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyTables",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r99",
                    "r100",
                    "r101",
                    "r128",
                    "r456"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/BalanceSheetsParenthetical",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockIssued1":  {
                "auth_ref":  [
                    "r81",
                    "r82",
                    "r83"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The fair value of stock issued in noncash financing activities.",
                            "label":  "Common stock issued in connection with payment of Series A Convertible Preferred Stock dividends in-kind"
                            }
                        }
                    },
                "localname":  "StockIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r46",
                    "r216",
                    "r256",
                    "r257",
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period as a result of the conversion of convertible securities.",
                            "label":  "Issuance of common stock in connection with extension of notes payable, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued in lieu of cash for services contributed to the entity.  Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
                            "label":  "Common stock shares issued for sevice, shares",
                            "verboseLabel":  "Stock issued during period for services, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesIssuedForServices",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/FairValueDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r256",
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Issuance of Series A Convertible Preferred Stock for cash, shares",
                            "terseLabel":  "Stock issued during period, shares",
                            "verboseLabel":  "Common stock shares issued during period, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesOther":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued attributable to transactions classified as other.",
                            "label":  "Issuance of common stock pursuant to cashless warrant exercise, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesOther",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r256",
                    "r263"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number, after forfeiture, of shares or units issued under share-based payment arrangement.  Excludes shares or units issued under employee stock ownership plan (ESOP).",
                            "label":  "Common stock, shares",
                            "verboseLabel":  "Stock issued during period for share based compensation, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r256",
                    "r263",
                    "r295"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Number of Options, Exercised"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfStockOptionActivityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities":  {
                "auth_ref":  [
                    "r47",
                    "r256",
                    "r263"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The gross value of stock issued during the period upon the conversion of convertible securities.",
                            "label":  "Issuance of common stock in connection with extension of notes payable"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueIssuedForServices":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued in lieu of cash for services contributed to the entity.  Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
                            "label":  "Common stock shares issued for sevice, value",
                            "verboseLabel":  "Stock issued during period for services, value"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueIssuedForServices",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/FairValueDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r256",
                    "r263"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Issuance of Series A Convertible Preferred Stock for cash",
                            "terseLabel":  "Stock issued during period, value",
                            "verboseLabel":  "Common stock shares issued during period, value"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueOther":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of shares of stock issued attributable to transactions classified as other.",
                            "label":  "Issuance of common stock pursuant to cashless warrant exercise"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueOther",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation":  {
                "auth_ref":  [
                    "r21",
                    "r22",
                    "r263",
                    "r284",
                    "r299"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value, after forfeiture, of shares issued under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Common stock",
                            "verboseLabel":  "Stock issued during period for share based compensation, value"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockOptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
                            "label":  "Equity Option [Member]"
                            }
                        }
                    },
                "localname":  "StockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfStockOptionsAssumptionUsedDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StockOptionPlanExpense":  {
                "auth_ref":  [
                    "r76"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/StatementsOfCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for option under share-based payment arrangement.",
                            "label":  "Stock or Unit Option Plan Expense",
                            "verboseLabel":  "Options"
                            }
                        }
                    },
                "localname":  "StockOptionPlanExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r22",
                    "r25",
                    "r26",
                    "r91",
                    "r148",
                    "r154",
                    "r389",
                    "r420"
                    ],
                "calculation":  {
                    "http://cellsource.com/role/BalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "periodEndLabel":  "Ending balance, value",
                            "periodStartLabel":  "Beginning balance, value",
                            "totalLabel":  "Total Stockholders\u2019 Deficiency"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets",
                    "http://cellsource.com/role/StatementsOfChangesInStockholdersDeficiency"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders\u2019 Deficiency:"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/BalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r89",
                    "r241",
                    "r244",
                    "r245",
                    "r246",
                    "r247",
                    "r248",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r255",
                    "r263",
                    "r265"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders\u2019 Deficiency"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StockholdersDeficiency"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsequentEventLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Detail information of subsequent event by type.  User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
                            "label":  "Subsequent Event [Line Items]"
                            }
                        }
                    },
                "localname":  "SubsequentEventLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventMember":  {
                "auth_ref":  [
                    "r397",
                    "r422"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event [Member]"
                            }
                        }
                    },
                "localname":  "SubsequentEventMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventTable":  {
                "auth_ref":  [
                    "r397",
                    "r422"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
                            "label":  "Subsequent Event [Table]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventTypeAxis":  {
                "auth_ref":  [
                    "r397",
                    "r422"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event Type [Axis]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventTypeDomain":  {
                "auth_ref":  [
                    "r397",
                    "r422"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlansDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for reporting subsequent events.",
                            "label":  "Subsequent Events, Policy [Policy Text Block]",
                            "verboseLabel":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "auth_ref":  [
                    "r421",
                    "r423"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
                            "label":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SubsequentEvents"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock":  {
                "auth_ref":  [
                    "r4"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern.  Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
                            "label":  "Going Concern and Management\u2019s Plans"
                            }
                        }
                    },
                "localname":  "SubstantialDoubtAboutGoingConcernTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/GoingConcernAndManagementsPlans"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SupplementalCashFlowInformationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental Disclosures of Cash Flow Information:"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowInformationAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain":  {
                "auth_ref":  [
                    "r149",
                    "r150",
                    "r151",
                    "r152",
                    "r153",
                    "r224",
                    "r254",
                    "r371",
                    "r424",
                    "r425",
                    "r426",
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r436",
                    "r437",
                    "r438",
                    "r439",
                    "r440",
                    "r441",
                    "r442",
                    "r443",
                    "r444",
                    "r445",
                    "r446",
                    "r447",
                    "r448",
                    "r449",
                    "r450",
                    "r451",
                    "r452",
                    "r453",
                    "r533",
                    "r534",
                    "r535",
                    "r536",
                    "r537",
                    "r538",
                    "r539"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
                            }
                        }
                    },
                "localname":  "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TypeOfArrangementAxis":  {
                "auth_ref":  [
                    "r354"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
                            }
                        }
                    },
                "localname":  "TypeOfArrangementAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_UnrecognizedTaxBenefits":  {
                "auth_ref":  [
                    "r318",
                    "r326"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrecognized tax benefits.",
                            "label":  "Unrecognized tax benefits"
                            }
                        }
                    },
                "localname":  "UnrecognizedTaxBenefits",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r132",
                    "r133",
                    "r134",
                    "r135",
                    "r136",
                    "r137",
                    "r138"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_WarrantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
                            "label":  "Warrant [Member]"
                            }
                        }
                    },
                "localname":  "WarrantMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/ScheduleOfOutstandingAndExercisableDetails",
                    "http://cellsource.com/role/ScheduleOfWeightedAverageDilutiveCommonSharesAnti-dilutiveDetails",
                    "http://cellsource.com/role/StockholdersDeficiencyDetailsNarrative",
                    "http://cellsource.com/role/StockholdersDeficiencyTables",
                    "http://cellsource.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WarrantsAndRightsOutstandingTerm":  {
                "auth_ref":  [
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Warrant term"
                            }
                        }
                    },
                "localname":  "WarrantsAndRightsOutstandingTerm",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
                            "label":  "Basic and Diluted"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://cellsource.com/role/StatementsOfOperations"
                    ],
                "xbrltype":  "sharesItemType"
                }
            },
        "unitCount":  4
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "105",
        "URI":  "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "105",
        "URI":  "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.M.Q2)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "55",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "320",
        "URI":  "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "321",
        "URI":  "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "321",
        "URI":  "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "321",
        "URI":  "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(3)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(4)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/topic&trid=2144648"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(20))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/topic&trid=2127136"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "460",
        "URI":  "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "460",
        "URI":  "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(f)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(i)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69B",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69C",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69E",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "40",
        "SubTopic":  "50",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "40",
        "SubTopic":  "50",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/topic&trid=2208564"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "50",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/topic&trid=2208762"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "710",
        "URI":  "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "710",
        "URI":  "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "710",
        "URI":  "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "10",
        "Topic":  "710",
        "URI":  "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "10",
        "Topic":  "710",
        "URI":  "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(ii)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(01)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(A)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(B)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(C)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(03)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.1)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b),(f)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.14)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(3)-(4)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.17)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a)(5))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(g)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.D.2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "730",
        "URI":  "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a),20,24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.5.Q1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.2)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.3)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.4)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.C)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19,20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "270",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/topic&trid=2144680"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "808",
        "URI":  "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4J",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4K",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/topic&trid=2197479"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(1)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20,24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(b)(2)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(4)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(1)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(2)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "60",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/topic&trid=2175825"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "40",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/subtopic&trid=51888271"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(2))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(1)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(5))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/topic&trid=2122745"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r423":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "855",
        "URI":  "http://asc.fasb.org/topic&trid=2122774"
        },
    "r424":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)(i)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r425":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)(ii)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r426":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r427":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r428":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r429":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r430":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r431":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r432":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r433":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r434":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r435":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r436":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r437":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
        },
    "r438":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
        },
    "r439":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.28,29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r440":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
        },
    "r441":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
        },
    "r442":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(4)(i)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
        },
    "r443":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r444":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r445":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r446":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(4)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r447":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(5)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r448":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(6)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r449":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(a)(7)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r450":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(b)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r451":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r452":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r453":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "50",
        "Subparagraph":  "(e)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
        },
    "r454":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
        },
    "r455":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "730",
        "Topic":  "912",
        "URI":  "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
        },
    "r456":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r457":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
        },
    "r458":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
        },
    "r459":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-30)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r460":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
        },
    "r461":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
        },
    "r462":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
        },
    "r463":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
        },
    "r464":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
        },
    "r465":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
        },
    "r466":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
        },
    "r467":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(1)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
        },
    "r468":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(2)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
        },
    "r469":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "940",
        "URI":  "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r470":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(1)(a))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r471":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r472":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(13))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r473":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(15)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r474":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(16))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r475":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r476":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(5))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r477":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r478":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(15))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r479":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.3,4)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r480":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "235",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
        },
    "r481":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "405",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
        },
    "r482":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
        },
    "r483":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r484":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r485":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(15)(b)(1))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r486":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16)(a))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r487":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r488":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(2))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r489":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.8)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r490":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r491":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r492":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.15(a))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r493":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r494":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r495":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r496":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
        },
    "r497":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
        },
    "r498":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r499":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/topic&trid=2122149"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.9)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r500":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r501":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r502":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r503":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(ii)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r504":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iii)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r505":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(iv)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r506":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r507":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r508":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "210",
        "Topic":  "946",
        "URI":  "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
        },
    "r509":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "210",
        "Topic":  "946",
        "URI":  "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
        },
    "r510":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.6-04(13))",
        "Topic":  "946",
        "URI":  "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
        },
    "r511":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "210",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
        },
    "r512":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "440",
        "Subparagraph":  "(a)",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
        },
    "r513":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Footnote 4))",
        "Topic":  "970",
        "URI":  "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r514":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(c)",
        "Topic":  "976",
        "URI":  "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
        },
    "r515":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "978",
        "URI":  "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
        },
    "r516":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "985",
        "URI":  "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
        },
    "r517":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12"
        },
    "r518":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r519":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
        },
    "r520":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-23"
        },
    "r521":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r522":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "g"
        },
    "r523":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12, 13, 15d"
        },
    "r524":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13e",
        "Subsection":  "4c"
        },
    "r525":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "14d",
        "Subsection":  "2b"
        },
    "r526":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "15",
        "Subsection":  "d"
        },
    "r527":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "14a",
        "Subsection":  "12"
        },
    "r528":  {
        "Name":  "Form 10-K",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "310"
        },
    "r529":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
        },
    "r530":  {
        "Name":  "Form 20-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "220",
        "Subsection":  "f"
        },
    "r531":  {
        "Name":  "Form 40-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "240",
        "Subsection":  "f"
        },
    "r532":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r533":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(a)",
        "Publisher":  "SEC",
        "Section":  "1402"
        },
    "r534":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(1)"
        },
    "r535":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)"
        },
    "r536":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(b)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(3)"
        },
    "r537":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(i)"
        },
    "r538":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(ii)"
        },
    "r539":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(c)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "Subparagraph":  "(2)(iii)"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
        },
    "r540":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r541":  {
        "Name":  "Securities Act",
        "Number":  "230",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r542":  {
        "Name":  "Securities Act",
        "Number":  "230",
        "Publisher":  "SEC",
        "Section":  "425"
        },
    "r543":  {
        "Name":  "Securities Act",
        "Number":  "7A",
        "Publisher":  "SEC",
        "Section":  "B",
        "Subsection":  "2"
        },
    "r544":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(01)",
        "Topic":  "848"
        },
    "r545":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Topic":  "848"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(10))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(4))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.7)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.8)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(c))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(f))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(1)(Note 1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(2))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(k)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.12-04(a))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/topic&trid=2122369"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
        }
    },
"version":  "2.1"
}


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/08/23  Cell Source, Inc.                 10-K       12/31/22   77:11M                                    M2 Compliance LLC/FA


27 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/21  Cell Source, Inc.                 10-Q        6/30/21   45:7M                                     M2 Compliance LLC/FA
 4/15/21  Cell Source, Inc.                 10-K       12/31/20   71:6.4M                                   Pubco Reporting … Inc/FA
11/13/20  Cell Source, Inc.                 10-Q        9/30/20   50:3.2M                                   Pubco Reporting … Inc/FA
 8/14/20  Cell Source, Inc.                 10-Q        6/30/20   47:2.8M                                   Pubco Reporting … Inc/FA
 5/15/20  Cell Source, Inc.                 10-Q        3/31/20   45:2.1M                                   Pubco Reporting … Inc/FA
 3/30/20  Cell Source, Inc.                 10-K       12/31/19   71:6.1M                                   Pubco Reporting … Inc/FA
 8/14/19  Cell Source, Inc.                 10-Q        6/30/19   49:14M                                    Global Fin’l Corp./FA
 6/19/19  Cell Source, Inc.                 10-K/A     12/31/18    5:245K                                   Global Fin’l Corp./FA
 5/20/19  Cell Source, Inc.                 10-Q        3/31/19   44:2.3M                                   Global Fin’l Corp./FA
 7/25/18  Cell Source, Inc.                 10-K       12/31/17   75:11M                                    Global Fin’l Corp./FA
 8/15/16  Cell Source, Inc.                 10-Q        6/30/16   47:3M                                     Global Fin’l Corp./FA
 5/13/16  Cell Source, Inc.                 10-Q        3/31/16   47:2.6M                                   Global Fin’l Corp./FA
 4/14/16  Cell Source, Inc.                 10-K       12/31/15   66:8.2M                                   Global Fin’l Corp./FA
 7/28/15  Cell Source, Inc.                 8-K:1,3,9   7/20/15    5:235K                                   Global Fin’l Corp./FA
 6/10/15  Cell Source, Inc.                 8-K:1,9     6/04/15    3:57K                                    Toppan Merrill/FA
 6/03/15  Cell Source, Inc.                 8-K:1,2,3,9 5/15/15    4:99K                                    Toppan Merrill/FA
 4/01/15  Cell Source, Inc.                 8-K:2,3,9   3/26/15    3:91K                                    Toppan Merrill/FA
 3/13/15  Cell Source, Inc.                 10-K       12/31/14   60:6.6M                                   Toppan Merrill/FA
12/02/14  Cell Source, Inc.                 8-K:2,9    11/26/14    2:28K                                    Toppan Merrill/FA
 9/23/14  Cell Source, Inc.                 S-1/A                 63:8.1M                                   Toppan Merrill/FA
 8/19/14  Cell Source, Inc.                 10-Q        6/30/14   50:3.1M                                   Toppan Merrill/FA
 8/08/14  Cell Source, Inc.                 S-1                   58:6.2M                                   Toppan Merrill/FA
 7/01/14  Cell Source, Inc.                 8-K:1,2,3,4 6/30/14   16:27M                                    Toppan Merrill/FA
 6/30/14  Cell Source, Inc.                 8-K:1,3,9   6/27/14    3:56K                                    Global Fin’l Corp./FA
 6/26/14  Cell Source, Inc.                 8-K:5,9     6/23/14    2:6K                                     Global Fin’l Corp./FA
 6/06/14  Cell Source, Inc.                 8-K:5,9     5/07/14    2:7K                                     Global Fin’l Corp./FA
 3/05/13  Cell Source, Inc.                 S-1                    7:396K                                   Global Fin’l Corp./FA
Top
Filing Submission 0001493152-22-010133   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 9:59:45.4am ET